IL103996A - Process for the production of mono-n-substituted tetraazacyclododecane and tetraazacyclo- tetradecane derivatives - Google Patents
Process for the production of mono-n-substituted tetraazacyclododecane and tetraazacyclo- tetradecane derivativesInfo
- Publication number
- IL103996A IL103996A IL103996A IL10399692A IL103996A IL 103996 A IL103996 A IL 103996A IL 103996 A IL103996 A IL 103996A IL 10399692 A IL10399692 A IL 10399692A IL 103996 A IL103996 A IL 103996A
- Authority
- IL
- Israel
- Prior art keywords
- optionally
- hours
- alkyl
- hydroxy
- room temperature
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 30
- 238000004519 manufacturing process Methods 0.000 title claims description 22
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 claims description 136
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 116
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 102
- -1 phenylenoxy groups Chemical group 0.000 claims description 97
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 87
- 239000002904 solvent Substances 0.000 claims description 65
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 61
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 52
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 48
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 44
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 37
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 36
- 229910052757 nitrogen Inorganic materials 0.000 claims description 35
- 239000000203 mixture Substances 0.000 claims description 34
- 150000001875 compounds Chemical class 0.000 claims description 32
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 32
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims description 31
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 31
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 30
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 claims description 30
- WMFOQBRAJBCJND-UHFFFAOYSA-M Lithium hydroxide Chemical compound [Li+].[OH-] WMFOQBRAJBCJND-UHFFFAOYSA-M 0.000 claims description 30
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 claims description 30
- 238000006243 chemical reaction Methods 0.000 claims description 27
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 26
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 22
- 125000004433 nitrogen atom Chemical group N* 0.000 claims description 21
- 125000006239 protecting group Chemical group 0.000 claims description 21
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 21
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 claims description 20
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 20
- QBPPRVHXOZRESW-UHFFFAOYSA-N 1,4,7,10-tetraazacyclododecane Chemical compound C1CNCCNCCNCCN1 QBPPRVHXOZRESW-UHFFFAOYSA-N 0.000 claims description 17
- 239000002253 acid Substances 0.000 claims description 17
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims description 17
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 17
- 125000003545 alkoxy group Chemical group 0.000 claims description 16
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 15
- 229910052794 bromium Inorganic materials 0.000 claims description 13
- 239000007795 chemical reaction product Substances 0.000 claims description 13
- 239000000460 chlorine Substances 0.000 claims description 13
- 239000013067 intermediate product Substances 0.000 claims description 13
- 229910052801 chlorine Inorganic materials 0.000 claims description 12
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 claims description 12
- 150000007529 inorganic bases Chemical class 0.000 claims description 12
- 239000003960 organic solvent Substances 0.000 claims description 12
- 125000004430 oxygen atom Chemical group O* 0.000 claims description 12
- 239000011541 reaction mixture Substances 0.000 claims description 12
- 238000003756 stirring Methods 0.000 claims description 12
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 claims description 11
- 125000000217 alkyl group Chemical group 0.000 claims description 11
- 229910052500 inorganic mineral Inorganic materials 0.000 claims description 11
- 239000011707 mineral Substances 0.000 claims description 11
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims description 10
- RQPZNWPYLFFXCP-UHFFFAOYSA-L barium dihydroxide Chemical compound [OH-].[OH-].[Ba+2] RQPZNWPYLFFXCP-UHFFFAOYSA-L 0.000 claims description 10
- 229910001863 barium hydroxide Inorganic materials 0.000 claims description 10
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 claims description 10
- 239000000920 calcium hydroxide Substances 0.000 claims description 10
- 229910001861 calcium hydroxide Inorganic materials 0.000 claims description 10
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims description 9
- 239000000010 aprotic solvent Substances 0.000 claims description 9
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims description 8
- 125000004122 cyclic group Chemical group 0.000 claims description 8
- 125000004356 hydroxy functional group Chemical group O* 0.000 claims description 8
- 229910052760 oxygen Inorganic materials 0.000 claims description 8
- 239000001301 oxygen Substances 0.000 claims description 8
- 229920006395 saturated elastomer Polymers 0.000 claims description 8
- 229910052717 sulfur Inorganic materials 0.000 claims description 8
- 125000004434 sulfur atom Chemical group 0.000 claims description 8
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims description 8
- MDAXKAUIABOHTD-UHFFFAOYSA-N 1,4,8,11-tetraazacyclotetradecane Chemical compound C1CNCCNCCCNCCNC1 MDAXKAUIABOHTD-UHFFFAOYSA-N 0.000 claims description 7
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 7
- 125000002947 alkylene group Chemical group 0.000 claims description 6
- 125000004682 aminothiocarbonyl group Chemical group NC(=S)* 0.000 claims description 5
- 150000002148 esters Chemical class 0.000 claims description 5
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 claims description 5
- 125000002768 hydroxyalkyl group Chemical group 0.000 claims description 5
- 125000001637 1-naphthyl group Chemical group [H]C1=C([H])C([H])=C2C(*)=C([H])C([H])=C([H])C2=C1[H] 0.000 claims description 4
- 125000001622 2-naphthyl group Chemical group [H]C1=C([H])C([H])=C2C([H])=C(*)C([H])=C([H])C2=C1[H] 0.000 claims description 4
- KZBUYRJDOAKODT-UHFFFAOYSA-N Chlorine Chemical compound ClCl KZBUYRJDOAKODT-UHFFFAOYSA-N 0.000 claims description 4
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 4
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 claims description 4
- 150000001408 amides Chemical class 0.000 claims description 4
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 4
- 125000000051 benzyloxy group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])O* 0.000 claims description 4
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 claims description 4
- 125000004432 carbon atom Chemical group C* 0.000 claims description 4
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims description 4
- 150000002118 epoxides Chemical class 0.000 claims description 4
- BLNWTAHYTCHDJH-UHFFFAOYSA-O hydroxy(oxo)azanium Chemical compound O[NH+]=O BLNWTAHYTCHDJH-UHFFFAOYSA-O 0.000 claims description 4
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 claims description 4
- 125000000843 phenylene group Chemical group C1(=C(C=CC=C1)*)* 0.000 claims description 4
- NOWKCMXCCJGMRR-UHFFFAOYSA-N Aziridine Chemical compound C1CN1 NOWKCMXCCJGMRR-UHFFFAOYSA-N 0.000 claims description 2
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 claims description 2
- 125000003368 amide group Chemical group 0.000 claims description 2
- 125000004397 aminosulfonyl group Chemical group NS(=O)(=O)* 0.000 claims description 2
- 238000001816 cooling Methods 0.000 claims description 2
- 239000012948 isocyanate Substances 0.000 claims description 2
- 150000002513 isocyanates Chemical class 0.000 claims description 2
- 150000002540 isothiocyanates Chemical class 0.000 claims description 2
- 229910052751 metal Inorganic materials 0.000 claims description 2
- 239000002184 metal Substances 0.000 claims description 2
- 150000002825 nitriles Chemical class 0.000 claims description 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 2
- 238000003745 diagnosis Methods 0.000 claims 1
- XMVJITFPVVRMHC-UHFFFAOYSA-N roxarsone Chemical group OC1=CC=C([As](O)(O)=O)C=C1[N+]([O-])=O XMVJITFPVVRMHC-UHFFFAOYSA-N 0.000 claims 1
- 238000001704 evaporation Methods 0.000 description 28
- 230000008020 evaporation Effects 0.000 description 28
- 238000004458 analytical method Methods 0.000 description 24
- 239000000126 substance Substances 0.000 description 24
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 22
- 239000002585 base Substances 0.000 description 21
- ZSXGLVDWWRXATF-UHFFFAOYSA-N N,N-dimethylformamide dimethyl acetal Chemical compound COC(OC)N(C)C ZSXGLVDWWRXATF-UHFFFAOYSA-N 0.000 description 14
- 150000003254 radicals Chemical class 0.000 description 14
- 230000002829 reductive effect Effects 0.000 description 14
- 239000012299 nitrogen atmosphere Substances 0.000 description 12
- 229910021529 ammonia Inorganic materials 0.000 description 11
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 10
- 150000002678 macrocyclic compounds Chemical class 0.000 description 10
- 239000000376 reactant Substances 0.000 description 10
- 239000000741 silica gel Substances 0.000 description 10
- 229910002027 silica gel Inorganic materials 0.000 description 10
- 239000012074 organic phase Substances 0.000 description 9
- 238000003786 synthesis reaction Methods 0.000 description 9
- BZLVMXJERCGZMT-UHFFFAOYSA-N Methyl tert-butyl ether Chemical group COC(C)(C)C BZLVMXJERCGZMT-UHFFFAOYSA-N 0.000 description 8
- 230000015572 biosynthetic process Effects 0.000 description 8
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 7
- 239000000758 substrate Substances 0.000 description 7
- 238000003776 cleavage reaction Methods 0.000 description 6
- 235000010755 mineral Nutrition 0.000 description 6
- 230000007017 scission Effects 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 125000001424 substituent group Chemical group 0.000 description 6
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 5
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 5
- 238000005059 solid analysis Methods 0.000 description 5
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 4
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 4
- 238000007363 ring formation reaction Methods 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 3
- 239000001257 hydrogen Substances 0.000 description 3
- 229910052739 hydrogen Inorganic materials 0.000 description 3
- 239000002243 precursor Substances 0.000 description 3
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 3
- 238000010992 reflux Methods 0.000 description 3
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 3
- 125000002221 trityl group Chemical group [H]C1=C([H])C([H])=C([H])C([H])=C1C([*])(C1=C(C(=C(C(=C1[H])[H])[H])[H])[H])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 3
- FPIGOBKNDYAZTP-UHFFFAOYSA-N 1,2-epoxy-3-(4-nitrophenoxy)propane Chemical compound C1=CC([N+](=O)[O-])=CC=C1OCC1OC1 FPIGOBKNDYAZTP-UHFFFAOYSA-N 0.000 description 2
- VBNWSEVVMYMVLC-UHFFFAOYSA-N 1-(4-methylphenyl)sulfonylaziridine Chemical compound C1=CC(C)=CC=C1S(=O)(=O)N1CC1 VBNWSEVVMYMVLC-UHFFFAOYSA-N 0.000 description 2
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 2
- 125000000954 2-hydroxyethyl group Chemical group [H]C([*])([H])C([H])([H])O[H] 0.000 description 2
- 125000004200 2-methoxyethyl group Chemical group [H]C([H])([H])OC([H])([H])C([H])([H])* 0.000 description 2
- QOXOZONBQWIKDA-UHFFFAOYSA-N 3-hydroxypropyl Chemical group [CH2]CCO QOXOZONBQWIKDA-UHFFFAOYSA-N 0.000 description 2
- ZNYRFEPBTVGZDN-UHFFFAOYSA-N 5S,6S-epoxy-15R-hydroxy-ETE Chemical compound COCCOCCOCCOCCO ZNYRFEPBTVGZDN-UHFFFAOYSA-N 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- GOOHAUXETOMSMM-UHFFFAOYSA-N Propylene oxide Chemical compound CC1CO1 GOOHAUXETOMSMM-UHFFFAOYSA-N 0.000 description 2
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 2
- CIUQDSCDWFSTQR-UHFFFAOYSA-N [C]1=CC=CC=C1 Chemical class [C]1=CC=CC=C1 CIUQDSCDWFSTQR-UHFFFAOYSA-N 0.000 description 2
- 229960000583 acetic acid Drugs 0.000 description 2
- 239000003513 alkali Substances 0.000 description 2
- 150000001336 alkenes Chemical class 0.000 description 2
- HUMNYLRZRPPJDN-UHFFFAOYSA-N benzaldehyde Chemical compound O=CC1=CC=CC=C1 HUMNYLRZRPPJDN-UHFFFAOYSA-N 0.000 description 2
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- JHIVVAPYMSGYDF-UHFFFAOYSA-N cyclohexanone Chemical compound O=C1CCCCC1 JHIVVAPYMSGYDF-UHFFFAOYSA-N 0.000 description 2
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 2
- 125000002704 decyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
- 229940039227 diagnostic agent Drugs 0.000 description 2
- 239000000032 diagnostic agent Substances 0.000 description 2
- 125000005982 diphenylmethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])(*)C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 238000007327 hydrogenolysis reaction Methods 0.000 description 2
- CBOIHMRHGLHBPB-UHFFFAOYSA-N hydroxymethyl Chemical compound O[CH2] CBOIHMRHGLHBPB-UHFFFAOYSA-N 0.000 description 2
- 239000000543 intermediate Substances 0.000 description 2
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 2
- 125000000555 isopropenyl group Chemical group [H]\C([H])=C(\*)C([H])([H])[H] 0.000 description 2
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 2
- 235000019341 magnesium sulphate Nutrition 0.000 description 2
- MJGFBOZCAJSGQW-UHFFFAOYSA-N mercury sodium Chemical compound [Na].[Hg] MJGFBOZCAJSGQW-UHFFFAOYSA-N 0.000 description 2
- 125000001421 myristyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 2
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 2
- 239000001103 potassium chloride Substances 0.000 description 2
- 235000011164 potassium chloride Nutrition 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 238000007127 saponification reaction Methods 0.000 description 2
- JLGLQAWTXXGVEM-UHFFFAOYSA-N triethylene glycol monomethyl ether Chemical compound COCCOCCOCCO JLGLQAWTXXGVEM-UHFFFAOYSA-N 0.000 description 2
- VOLGAXAGEUPBDM-UHFFFAOYSA-N $l^{1}-oxidanylethane Chemical compound CC[O] VOLGAXAGEUPBDM-UHFFFAOYSA-N 0.000 description 1
- HLRWRACNIJFYEO-UHFFFAOYSA-N 1,4,7,10-tetrazacyclotetradecane Chemical compound C1CCNCCNCCNCCNC1 HLRWRACNIJFYEO-UHFFFAOYSA-N 0.000 description 1
- ULIBLGGHYYDEJD-UHFFFAOYSA-N 1-methylsulfonylaziridine Chemical compound CS(=O)(=O)N1CC1 ULIBLGGHYYDEJD-UHFFFAOYSA-N 0.000 description 1
- VNONLLDTIHTNMX-UHFFFAOYSA-N 3-(1,4,7,10-tetrazacyclododec-1-yl)propanenitrile Chemical compound N#CCCN1CCNCCNCCNCC1 VNONLLDTIHTNMX-UHFFFAOYSA-N 0.000 description 1
- NAPAGVOSAQOZRS-UHFFFAOYSA-N 3-(1,4,7,10-tetrazacyclododec-1-yl)propanoic acid Chemical compound OC(=O)CCN1CCNCCNCCNCC1 NAPAGVOSAQOZRS-UHFFFAOYSA-N 0.000 description 1
- RVWQFEDQYADWSH-UHFFFAOYSA-N 3-(1,4,8,11-tetrazacyclotetradec-1-yl)propanenitrile Chemical compound N#CCCN1CCCNCCNCCCNCC1 RVWQFEDQYADWSH-UHFFFAOYSA-N 0.000 description 1
- XKTYXVDYIKIYJP-UHFFFAOYSA-N 3h-dioxole Chemical compound C1OOC=C1 XKTYXVDYIKIYJP-UHFFFAOYSA-N 0.000 description 1
- GEKNCWQQNMEIMS-UHFFFAOYSA-N 4,4-dimethyl-3,5,8-trioxabicyclo[5.1.0]octane Chemical compound C1OC(C)(C)OCC2OC21 GEKNCWQQNMEIMS-UHFFFAOYSA-N 0.000 description 1
- 125000004217 4-methoxybenzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1OC([H])([H])[H])C([H])([H])* 0.000 description 1
- PZASAAIJIFDWSB-CKPDSHCKSA-N 8-[(1S)-1-[8-(trifluoromethyl)-7-[4-(trifluoromethyl)cyclohexyl]oxynaphthalen-2-yl]ethyl]-8-azabicyclo[3.2.1]octane-3-carboxylic acid Chemical compound FC(F)(F)C=1C2=CC([C@@H](N3C4CCC3CC(C4)C(O)=O)C)=CC=C2C=CC=1OC1CCC(C(F)(F)F)CC1 PZASAAIJIFDWSB-CKPDSHCKSA-N 0.000 description 1
- MITGKKFYIJJQGL-UHFFFAOYSA-N 9-(4-chlorobenzoyl)-6-methylsulfonyl-2,3-dihydro-1H-carbazol-4-one Chemical compound ClC1=CC=C(C(=O)N2C3=CC=C(C=C3C=3C(CCCC2=3)=O)S(=O)(=O)C)C=C1 MITGKKFYIJJQGL-UHFFFAOYSA-N 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical class [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 description 1
- 239000004593 Epoxy Substances 0.000 description 1
- JIGUQPWFLRLWPJ-UHFFFAOYSA-N Ethyl acrylate Chemical compound CCOC(=O)C=C JIGUQPWFLRLWPJ-UHFFFAOYSA-N 0.000 description 1
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 1
- 238000005684 Liebig rearrangement reaction Methods 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- YYILQFNZULLVNL-UHFFFAOYSA-N [4-[2-hydroxy-3-(1,4,8,11-tetrazacyclotetradec-1-yl)propoxy]phenyl] nitrate Chemical compound C1CCNCCNCCCNCCN1CC(O)COC1=CC=C(O[N+]([O-])=O)C=C1 YYILQFNZULLVNL-UHFFFAOYSA-N 0.000 description 1
- IKHGUXGNUITLKF-XPULMUKRSA-N acetaldehyde Chemical compound [14CH]([14CH3])=O IKHGUXGNUITLKF-XPULMUKRSA-N 0.000 description 1
- 238000010306 acid treatment Methods 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 150000007933 aliphatic carboxylic acids Chemical class 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 125000004453 alkoxycarbonyl group Chemical group 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 159000000032 aromatic acids Chemical class 0.000 description 1
- 125000003710 aryl alkyl group Chemical group 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 238000013375 chromatographic separation Methods 0.000 description 1
- 229940039231 contrast media Drugs 0.000 description 1
- 239000002872 contrast media Substances 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- GYZLOYUZLJXAJU-UHFFFAOYSA-N diglycidyl ether Chemical compound C1OC1COCC1CO1 GYZLOYUZLJXAJU-UHFFFAOYSA-N 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 239000000539 dimer Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000005868 electrolysis reaction Methods 0.000 description 1
- 125000004185 ester group Chemical group 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- WIZCNOCPILKZCE-UHFFFAOYSA-N ethyl 3-(7-formamido-1,4,7,10-tetrazacyclododec-1-yl)propanoate Chemical compound CCOC(=O)CCN1CCNCCN(NC=O)CCNCC1 WIZCNOCPILKZCE-UHFFFAOYSA-N 0.000 description 1
- 125000004494 ethyl ester group Chemical group 0.000 description 1
- 239000012362 glacial acetic acid Substances 0.000 description 1
- 125000000623 heterocyclic group Chemical group 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 description 1
- 125000002632 imidazolidinyl group Chemical group 0.000 description 1
- 125000001841 imino group Chemical group [H]N=* 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 239000012280 lithium aluminium hydride Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 125000002757 morpholinyl group Chemical group 0.000 description 1
- WOANNRLAJDGARY-UHFFFAOYSA-N n-[2-(1,4,7,10-tetrazacyclododec-1-yl)ethyl]methanesulfonamide Chemical compound CS(=O)(=O)NCCN1CCNCCNCCNCC1 WOANNRLAJDGARY-UHFFFAOYSA-N 0.000 description 1
- MZTAXACBNCJVJC-UHFFFAOYSA-N n-[7-[2-[(4-methylphenyl)sulfonylamino]ethyl]-1,4,7,10-tetrazacyclododec-1-yl]formamide Chemical compound C1=CC(C)=CC=C1S(=O)(=O)NCCN1CCNCCN(NC=O)CCNCC1 MZTAXACBNCJVJC-UHFFFAOYSA-N 0.000 description 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- LOHQJWJZAHGMLY-UHFFFAOYSA-N n-phenyl-1,4,7,10-tetrazacyclododecane-1-carboxamide Chemical compound C1CNCCNCCNCCN1C(=O)NC1=CC=CC=C1 LOHQJWJZAHGMLY-UHFFFAOYSA-N 0.000 description 1
- 238000005580 one pot reaction Methods 0.000 description 1
- 125000000160 oxazolidinyl group Chemical group 0.000 description 1
- 125000006503 p-nitrobenzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1[N+]([O-])=O)C([H])([H])* 0.000 description 1
- QNGNSVIICDLXHT-UHFFFAOYSA-N para-ethylbenzaldehyde Natural products CCC1=CC=C(C=O)C=C1 QNGNSVIICDLXHT-UHFFFAOYSA-N 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- DGTNSSLYPYDJGL-UHFFFAOYSA-N phenyl isocyanate Chemical compound O=C=NC1=CC=CC=C1 DGTNSSLYPYDJGL-UHFFFAOYSA-N 0.000 description 1
- 125000004193 piperazinyl group Chemical group 0.000 description 1
- 125000005936 piperidyl group Chemical group 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 229920005862 polyol Polymers 0.000 description 1
- 150000003077 polyols Chemical class 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 125000003072 pyrazolidinyl group Chemical group 0.000 description 1
- 125000002755 pyrazolinyl group Chemical group 0.000 description 1
- 125000000719 pyrrolidinyl group Chemical group 0.000 description 1
- 125000001422 pyrrolinyl group Chemical group 0.000 description 1
- 238000006894 reductive elimination reaction Methods 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 1
- 125000004665 trialkylsilyl group Chemical group 0.000 description 1
- ITMCEJHCFYSIIV-UHFFFAOYSA-M triflate Chemical compound [O-]S(=O)(=O)C(F)(F)F ITMCEJHCFYSIIV-UHFFFAOYSA-M 0.000 description 1
- 125000000026 trimethylsilyl group Chemical group [H]C([H])([H])[Si]([*])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- JQSHBVHOMNKWFT-DTORHVGOSA-N varenicline Chemical compound C12=CC3=NC=CN=C3C=C2[C@H]2C[C@@H]1CNC2 JQSHBVHOMNKWFT-DTORHVGOSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
- C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Abstract
A novel process for the preparation of mono-N-substituted tetraazamacrocycles is described.
Description
103,996/2 Ί πι^ ^ΝΐΝΝΊυυ ηπ^ιη ρ?ηη Τ\ΓΗ Ν-1 θ αΠΙΟΠ ρ7ΝΊϋϋ^ρ^ΝΤΣΧΝΊ \?1 PROCESS FOR THE PRODUCTION OF MONO-N-SUBSTITUTED TETRAAZACYCLODODECANE AND TETRAAZACYCLOTETRADECANE DERIVATIVES 1 103,996/2 The present invention relates to a process for the production of mono-N-substituted tetraazacyclododecane and tetraazacyclotetradecane derivatives.
Background of the Invention Mono-N-substituted tetraaza macrocycles of general formula I: in which: n stands for the numbers 2 or 3; R stands for a β-carboxy alkyl or β-alkoxycarbonyl alkyl, β-cyanide alkyl, β-carboxamido alkyl, β-hydroxy alkyl, aminocarbonyi, aminothiocarbonyl, β-sulfamoylalkyl radical or for a second tetraazacyclododecane or tetraazacyclotetradecane molecule bound by a bis^-hydroxy)-alkylene chain, and carboxyl and hydroxy groups are present optionally in protected form, are important precursors of tri-N-carboxyalkyl, preferably tri-N-carboxymethyl, substituted tetraaza macrocycles, - 2 - 103,996/2 which are used as diagnostic agents and therapeutic agents in the form of their complexes with metal ions of atomic numbers 21 to 29, 31, 32, 38, 39, 42-44, 49 or 57-83 (see European patent application publication no. 255471) .
Because of their importance as key compounds for these complexes, above all for the preferred NMR diagnostic agents (Macrocyclic Chemistry Congress, Hamburg 1988) , production of mono-N-substituted tetraaza macrocycles has been attempted in different ways, but without a satisfactory method of synthesis previously having been found.
For example, a statistical monoalkylation or monoacylation of unsubstituted tetraaza macrocycles has been described, which, however, is not suitable at least for the production of sizable amounts of substance because of the great excess of relatively costly initial amine to be used, partially very expensive chromatographic separation of the product from the initial material as well as in most cases quite moderate yields, [see Kaden, Helv. Chim. (Swiss Chem.) Acta 69, 2081 (1986); Kimura, J. Chem.
Soc. Chem. Commun. 1158 (1986) ; Kaden, Top. Curr. Chem. 121, 157 (1984); European Patent Application No. 296522, corresponding to IL 86835; and European Application 353450.] If it is desired - in contrast to the above-described statistical monosubstitution — to perform a specific monosubstitution, two variants are possible: a) reaction of a tetraaza macrocycle, provided with three nitrogen protecting groups, which was obtained by statistical trisubstitution, b) reaction of a tetraaza macrocycle, provided with three nitrogen protecting groups, which was produced by specific synthesis.
In the first-mentioned variant, the precursor carrying the protecting groups (e.g., tosylate, benzoate) on three nitrogen atoms is produced by statistical trisubstitution of an unsubstituted tetraaza macrocycle, so that the above- mentioned drawbacks of a statistical reaction, such as low yields, separating problems (particularly, in the production of sizable amounts of substance) also occur here [see, e.g., Macrocyclic Chemistry Congress, Hamburg 1988]. After the subsequent specific monosubstitution to introduce substituent R [Ciampolini, J. Chem. Soc. Chem. Commun. 998 (1984): Kaden, Helv. Chim. Acta 66, 861 (1983); Basefield, Inorg. Chem. 25, 4663 (1986)], the protecting groups on the three nitrogen atoms have to be removed, e.g., by alkali metal in ammonia [Helv. Chim. Acta, 56, 2216 (1973) ; Helv.
Chim. Acta 59, 1566 (1976); J. Org. Chem. 53, 3521 (1988)], lithium aluminum hydride [F. Voegtle; Liebigs Ann. Chem. (1977) , 1344], Red-Al(R) [E. H. Gold, J. Org. Chem. (1972), 37, 2208], Na-Hg [M. Kellog, J. Org. Chem. 1984, 49, 110], electrolysis [M. Hesse, Helv. Chim. Acta 71 (1988), 7, 1708] or hydrobromic acid/phenol/glacial acetic acid [N. G. Lukyanenko, Synthesis, 1988, 355]. These processes of the cleavage of the protecting groups are generally connected with poor yields, limit the batch size with respect to the amount of reagent to be used (e.g. , in the Na-Hg method) and above all cannot be used in the case of substituents, which carry sensitive groups (e.g., hydroxyalkyl) .
If the procedure is performed according to variant b) , i.e., if it is desired to produce the tetraaza macrocycle precursor carrying protecting groups on three nitrogen atoms by specific synthesis, a start is made from two reactants, which are cyclized according to methods known in the literature [e.g., Rich an, Org. Synthesis 5_8, 86 (1978) ; Atkins, J. Amer. Chem. Soc. 96, 2268 (1974)]; one of the two reactants contains a protected nitrogen atom and carries, on the chain end, two volatile groups (e.g., bromine, mesyloxy, tosyloxy, triflate or alkoxycarbonyl groups) , which are nucleophilically displaced from the terminal nitrogen atoms of the second reactant, of a — unlike the first reactant — protected triaza compound.
(If a reactant with two terminal ester groups is used, the two amide groupings resulting by the cyclization — preferably with diborane in THF — have to be reduced. But especially this cyclization variant is unsuitable for the production of substantial amounts of substance, since this reaction is to be performed in the highest possible dilution, to avoid, e.g., polymerization reactions: see Tabushi, Tetrahed. Lett. 12, 1049 (1977); Kaden, Inorg. Chem. 25, 321 (1986) . Also, the working up of the subsequent diborane reduction — again above all in greater batches — is not without problems . ) After cleavage of one protecting group, the thus released imino grouping can be alkylated or acylated. As an example, there can be mentioned the reaction of the disodium salt of Ν,Ν' ,N"-tris- (p-tolylsulfonyl) diethylene triamine [Ciampolini, J. Chem. Soc. Chem. Commun. 998 (1984)] with N-bis- (2-methanesulfonyloxy-ethyl) -triphenylmethylamine in dimethylformamide at 80-150°C with subsequent cleavage of the trityl group under acid conditions. The yields of both reaction steps are generally poor. Also, this variant b) is affected with the drawbacks mentioned under a) regarding the cleavage of three protecting groups coming from the second reactant.
Besides the previously presented process of the statistical and specific monosubstitution, a specific ring synthesis, in which desired substituent R already is contained in one of the two reactants to be used in the cyclization reaction, is also possible.
Besides the problems, already described above, of the cleavage of the protecting groups, it has turned out that the thus performed cyclizations generally take place with smaller yields — as compared to the reactions of the reactant provided only with protecting groups — [see Atkins, J. Amer. Chem. Soc. 96, 2268 (1974); Richman, Org. Synthe-sis 58/ 86 (1978); Fabbrizzi, Inorg. Chem. 25, 4131 (1986); 5 103,996/2 Gazetta, Chimica Italiana 1 15, 399 (1985)]. Further, the reactants carrying substituent R first have to be specially synthesized in a reaction sequence often comprising several steps [see, e.g., Bulkowski, J. Org. Chem. 47, 412 (1982)].
Despite varied efforts, it therefore previously has not been possible to find a satisfactory method of synthesis for mono-N-substituted tetraaza macrocycles of general formula I, which are to be considered as key compounds for the tri-N-carboxyalkyl metal complexes being used as valuable NMR and x-ray contrast media.
Summary of the Invention An object of the invention, therefore, is to make available a process for production of mono-N-substituted tetraaza macrocycles, which is suitable above all for the production of substantial amounts of substance.
Upon further study of the specification and appended claims, further objects and advantages of this invention will become apparent to those skilled in the art.
These objects are achieved by the present invention.
Thus, the invention provides a process for the production of mono-N-substituted tetraazacyclododecane and tetraazacyclotetradecane derivatives of general formula I: in which: n stands for the numbers 2 or 3; 103,996/ 3 R stands for a β-carboxy alkyl or β-alkoxycarbonyl alkyl, β-cyanide alkyl, β-carboxamido alkyl, β-hydroxy alkyl, aminocarbonyl, aminothiocarbonyl, β-sulfamoylalkyl radical or for a second tetraazacyclododecane or tetraazacyclotetradecane molecule bound by a bis^-hydroxy)-alkylene chain, wherein "alkyl" in β-carboxy alkyl, β-alkoxycarbonyl alkyl, β-cyanide alkyl, and β-carboxamido alkyl stands for -CR^-CHR1-; "amido" in β-carboxamido alkyl stands for CONR5R6; "alkyl" in β-hydroxy alkyl stands for -CHR7CHR8-; "amino" in aminocarbonyl and aminothiocarbonyl stands for X 6A 103,996/ 1 (with. X in the meaning of an oxygen or sulfur atom), "sulfamoyl" in P-sul&moylalkyl stands for -NHS02Rl°; and "alkylene" in bis(p- hydroxy)-alkylene stands for K R1 stands for a hydrogen atom, a straight-chain or cyclic Ci-Ce alkyl, a phenyl or benzyl group in which the phenyl or benzyl group can be substituted respectively by 1 to 2 chlorine, bromine, nitro, C 1-C7 alkoxy, C7-Ci0 aralkoxy and/or C02R4 radicals, with R4 meaning a hydrogen atom, a Ci.C6 alkyl, phenyl or benzyl group; R2 and R3, independent of one another, each stand for R1 or a CO2R4 group; R5 and R6, independent of one another, each stand for a hydrogen atom, a saturated or unsaturated, straight-chain, branched-chain or cyclic hydrocarbon radical with up to 16 carbon atoms optionally interrupted by 1 to 8 oxygen atoms or 1 to 3 phenylene or phenylenoxy groups, and optionally substituted by 1 to 5 hydroxy groups or 1 to 2 C02R4 radicals; for phenyl or benzyl radicals optionally substituted by 1 to 3 hydroxy or Cp alkoxy groups; or R5 and R6 together with the nitrogen atom stand for a saturated or unsaturated, 5- or 6-ring oxygen, sulfur atom or carbonyl group optionally containing another nitrogen, which optionally is substituted by 1 to 3 CrC6 alkyl radicals optionally substituted by 1 to 3 hydroxy radicals, and optionally present hydroxy and/or carboxyl groups optionally are protected; R and R , independent of one another, respectively stand for a hydrogen atom, a C1-C20 alkyl radical, optionally interrupted by 1 to 10 oxygen atoms, a phenylene, phenylenoxy or phenylenedioxy group, which optionally is substituted by 1 to 3 CrC6 alkyl, 1 to 3 trifluoromethyl, 1 to 7 hydroxy, 1 to 3 CrC7 alkoxy, 1 to 3 CrC10 aralkoxy, 1 to 2 C02R4 and/or 1 to 2 phenoxy or phenyl groups optionally substituted by 1 to 2 chlorine, 6B 103,996/ l bromine, m'tro or Ci-C^ alkoxy radicals, and the optionally present hydroxy radicals optionally are present in protected form; R9 stands for a phenyl, 1 or 2 naphthyl or straight-chain or cyclic Ci-C6 alkyl group; R10 stands for a CrC6 alkyl, -CF3 or a phenyl group optionally substituted by a C\-C6 alkyl, chlorine, bromine, or nitro radical; K stands for a C0-CI6 alkylene chain optionally substituted by 1 to 6 hydroxy, 1 to 6 C1-C7 hydroxyalkyl, 1 to 8 CrC7 alkoxy, 1 to 8 C7-Ci0 aralkoxy and/or 1 to 2 benzyloxy groups, and optionally interrupted by 1 to 6 oxygen atoms, 1 to 2 phenylene, phenylenoxy or phenylenedioxy groups; and wherein carboxyl and hydroxy groups are present optionally in protected form; characterized in that the compounds of general formula Π obtained from 1,4,7, 10-tetraazacyclododecane or 1,4,8,11-tetraazacyclotetradecane are reacted with an α,β-unsaturated ester, amide or nitrile, or an epoxide, isocyanate, isothiocyanate, aziridine or a bisepoxide, with or without solvent, at 0-220°C, preferably room temperature to 210°C, within 1 to 48 hours, preferably 5 to 12 hours, optionally at a pressure up to 100 atm; then the thus-obtained reaction mixture, after cooling to -20-80°C, preferably 0-30°C, is mixed with a mixture of water/organic solvent and stirred 6C 103,996/1 for 0.5-12 hours, preferably 0.5-3 hours at -20°C to room temperature, preferably 0°C to room temperature; then the thus-formed, optionally to be isolated, intermediate products carrying a formyl group on a nitrogen atom are reacted by adding an inorganic base or an acid at 0-150°C, preferably room temperature to 120°C, within 1 to 72 hours, preferably 6 to 24 hours, with stirring, optionally followed by subsequent removal of protecting groups in a way usual in the art, to obtain the end product of formula I, which can then be isolated in a way known in the art, preferably as hydrochloride.
The tetraazatricyclotridecane or tetraazatricyclopenta-decane of general formula II used as intermediates are accessible according to methods known in the literature, e.g., by reacting 1,4,7,10-tetraazacyclododecane or 1,4,8,11-tetraazacyclotetradecane with dimethylformamide-dimethylacetal (US patents 4,085,106 and 4,130,715), J. Am. Chem. SOC. 102, 6364 (1980), EP 292 689.
Advantageously, this reaction step is included in the process according to the invention, without the intermediates of general formula II having to be isolated ("one-pot reaction") .
A special embodiment of the process according to the invention is the production of compounds of general formula I with R2 R1 I I R meaning a —C—CH-A group, in which R1 stands for a hydrogen atom, a straight-chain or cyclic Ct-C6 alkyl, a phenyl or benzyl group — in which the phenyl or benzyl group can be substituted respectively by 1 to 2 chlorine, bromine, nitro, C^-C7 alkoxy, C7-C10 4 . 4 . aralkoxy, and/or C02R radicals with„R meaning a hydrogen atom, a C -C6 alkyl, phenyl or benzyl group, 2 3 · R and R , independent of one another, each stand for 1 4 R or a C02R group, R5 4 / A stands for a CN, C02R or CON radical, V in which R5 and R6, independent of one another, each stand for a hydrogen atom, a saturated or unsaturated, straight-chain, branched-chain or cyclic hydrocarbon radical with up to 16 C atoms, optionally interrupted by 1 to 8 oxygen atoms, or 1 to 3 phenylene or phenylenoxy groups, and optionally substituted by 1 to 5 hydroxy groups, or 1 to 2 C02R radicals; for phenyl or benzyl radicals optionally - 8 - substituted by 1 to 3 hydroxy or C^-C6 alkoxy groups; or R and R6 together with the nitrogen atom stand for a saturated or unsaturated 5- or 6-ring, optionally containing another nitrogen, oxygen, sulfur atom or a carbonyl group, which optionally is substituted by 1 to 3 C-C6 alkyl radicals optionally substituted by 1 to 3 hydroxy groups, and optionally present hydroxy and/or carboxyl groups optionally are protected, characterized in that tetraazatricyclotridecane or tetraazatricyclopentadecane is reacted with a feedstock of general formula III in which R1, R2, R3 and A have the above-indicated meanings, and optionally present hydroxy and/or carboxyl groups are optionally protected, with or without solvent, preferably aprotic solvents, such as, e.g. , benzene, toluene, dich1oromethane, tetrahydrofuran, dioxane, acetonitrile, dimethylformamide, hexane or ether, are used as solvent, at 0°C to 210°C, preferably 50°C to 180°C (and in the case of the higher reaction temperature, the solvent used optionally to dissolve the added feedstock of general formula III was previously distilled off in a vacuum) , within 12 to 48, preferably 5 to 12 hours. The thus obtained reaction mixture is cooled to -20°C to 80°C, preferably 0° to 30°C, mixed with a mixture of water/organic solvent, such as, e.g., methanol, ethanol, isopropanol, tetrahydrofuran or dioxane, and stirred for 0.5 to 12 hours, preferably 0.5 to 3 hours, at -20°C to room temperature, preferably 0°C to room temperature. The thus formed — optionally to be isolated — intermediate product carrying a formyl group on a nitrogen atom is reacted by adding an inorganic base such - 9 - as, e.g., lithium hydroxide, sodium hydroxide, potassium hydroxide, barium hydroxide or calcium hydroxide, preferably sodium hydroxide and potassium hydroxide, or a mineral acid, such as, e.g., hydrochloric, sulfuric or hydrobromic acid, preferably hydrochloric acid, at 0°C to 150°C, preferably room temperature to 120°C, within 1 to 72 hours, preferably 6 to 24 hours, with stirring optionally followed by subsequent removal of protecting groups in a way usual in the art — to obtain the end product of formula I, which can then be isolated in a way known in the art, preferably as hydrochloride.
If R1 stands for a ^-C6 alkyl group, the methyl and ethyl group is preferred. Other preferred radicals for R are the hydrogen atom and the optionally substituted phenyl radical. As preferred substituents on the phenyl ring, the nitro group, the ^-C7 alkoxy radical, above all the methoxy and ethoxy radical, and the C02R radical, can be mentioned, with R4 being preferably hydrogen, methyl, ethyl, t-butyl or benzyl.
As preferred radicals standing for R5 and R6, hydrogen, methyl, ethyl, 2-hydroxyethyl, 2-hydroxy-l- (hydroxymethyl) -ethyl, 1- (hydroxymethyl) -ethyl, propyl, isopropenyl, 2-hydroxypropyl, 3-hydroxypropyl, 2,3-dihydroxypropyl, butyl, isobutyl, isobutenyl, 2 -hydroxybuty1 , 3-hydroxybutyl, 4-hydroxybuty1, 2-, 3- and 4-hydroxy-2-methylbutyl, 2- and 3-hydroxyisobutyl, 2,3,4-trihydroxybutyl , 1, 2 , -trihydroxybutyl , pentyl, cyclopentyl, 2-methoxyethyl, hexyl, decyl, tetradecyl, triethylene glycol methyl ether, tetraethylene glycol methyl ether and methoxybenzyl group can be mentioned. The amide radical can also be a heterocyclic 5- or 6-ring formed with the inclusion of the amide nitrogen. As examples, there can be mentioned: pyrrolidinyl, piperidyl, pyrazolidinyl, pyrrolinyl, pyrazolinyl, piperazinyl, morpholinyl, imidazolidinyl , oxazolidinyl , and thiazolidiny1. - 10 - In substrate III, optionally present carboxyl and/or hydroxy groups are present preferably in protected form.
As acid protecting groups, lower alkyl (e.g., C ) , aryl (e.g., C6.10) and aralkyl (e.g., C7.12) groups, for example, the methyl, ethyl, propyl, n-butyl, t-butyl, phenyl, benzyl, diphenylmethyl, triphenylmethyl, bis (p-nitrophenyl) -methyl group as well as trialkylsilyl (e.g., with C^-alkyl groups) groups, are suitable.
The cleavage of the protecting groups takes place according to the processes known to one skilled in the art, for example, by hydrolysis, hydrogenolysis, alkaline saponification of the esters with alkali in aqueous alcoholic solution at temperatures of 0 to 50°C, acid saponification with mineral acids or in the case of, e.g., tert-butyl esters with the help of trifluoroacetic acid.
As hydroxy protecting groups, e.g., benzyl, 4-methoxybenzyl, 4-nitrobenzyl, trityl, diphenylmethyl, trimethylsilyl, dimethyl-t-butylsilyl, and diphenyl-t-butylsilyl groups are suitable.
The hydroxy groups can also be present, e.g., as THP-ether, a-alkoxyethylether (e.g., with C -alkoxy groups) , MEM-ether or as esters with aromatic or aliphatic carboxylic acids, such as, e.g., acetic acid or benzoic acid. In the case of polyols, the hydroxy groups can also be protected in the form of ketals with, e.g., acetone, acetaldehyde, cyclohexanone or benzaldehyde.
The hydroxy protecting groups can be released according to the methods in the literature known to one skilled in the art, e.g. , by hydrogenolysis, reductive cleavage with lithium/ammonia, acid treatment of the ethers and ketals or alkali treatment of the esters (see, e.g., "Protective Groups in Organic Synthesis," T. W. Greene, John Wiley and Sons 1981) .
Another special embodiment of the process according to the invention is the production of compounds of general formula I with R meaning a - 11 - OH -CH-C IH-R. group, in which 7 8 R and R , independent of one another, respectively stand for a hydrogen atom, a C^-C2Q alkyl radical, optionally interrupted by 1 to 10 oxygen atoms, a phenylene, phenylenoxy or phenylenedioxy group, which optionally is substituted by 1 to 3 ^-C6 alkyl, 1 to 3 trifluoromethyl, 1 to 7 hydroxy, 1 to 3 C-C7 alkoxy, 1 to 3 C7-C10 aralkoxy, 1 to 2 C02R and/or 1 to 2 phenoxy or phenyl groups optionally substituted by 1 to 2 chlorine, bromine, nitro or C^-C6 alkoxy radicals, and the optionally present hydroxy radicals are optionally in protected form, characterized in that tetraa z atr icyc lotr idecane or tetraazatricyclopentadecane is reacted with a feedstock of general formula IV R7 R8 7 8 in which R and R have the above-indicated meaning and wherein optionally present hydroxy and/or carboxyl groups optionally are protected, with or without solvent, preferably aprotic solvents, such as, e.g., benzene, toluene, dichloromethane, tetrahydrofuran, dioxane, acetonitrile, dimethylformamide, dimethylacetamide, dimethylsulfoxide, hexane or ether are used as solvent, at 0°C to 220°C, preferably 50°C to 180°C (and in the case of the higher reaction temperature, the solvent optionally used to dissolve the added feedstock of general formula IV was previously distilled off in a vacuum) or in an autoclave at an excess pressure of 1 to 100 atm. within 1 to 48 hours, preferably 5 to 12 hours. The thus obtained reaction mixture is cooled to -20°C to 80°C, preferably 0°C to 30°C, mixed with a mixture of water/organic solvent, such as, e-g-, methanol, ethanol, isopropanol, tetrahydrofuran or dioxane and stirred for 0.5 to 12 hours, preferably 0.5 to 3 hours, at -20 °C to room temperature, preferably 0°C to room temperature. The thus formed — optionally to be isolated — intermediate product carrying a formyl group on a nitrogen atom is reacted by adding an inorganic base, such as, e.g. , lithium hydroxide, sodium hydroxide, potassium hydroxide, barium hydroxide or calcium hydroxide, preferably sodium hydroxide and potassium hydroxide, or a mineral acid, such as, e.g., hydrochloric, sulfuric or hydrobromic acid, preferably hydrochloric acid, at 0°C to 150 °C, preferably room temperature to 120 °C, within 1 to 72 hours, preferably 6 to 24 hours, with stirring — optionally followed by subsequent removal of the protecting groups in a way usual in the art — to obtain the end product of formula I, which can then be isolated in a way known in the art, preferably as hydrochloride . 7 8 Preferred radicals R and R are hydrogen, methyl, ethyl, hydroxymethyl , 2-hydroxyethyl , 2 -hydroxy- 1- (hydroxymethyl) -ethyl , 1- (hydroxymethyl) -ethyl , propyl , isopropenyl, 2 -hydroxypropy1 , 3 -hydroxypropyl , 2 , 3-dihydroxypropyl , butyl, isobutyl, isobutenyl, 2-hydroxybuty1 , 3-hydroxybuty1 , 4-hydroxybuty1 , 2-, 3- and 4-hydroxy-2-methylbutyl , 2- and 3-hydrox isobuty1 , 2,3,4-trihydroxybutyl , 1 , 2 , -trihydroxybutyl , pentyl , cyclopentyl, 2-methoxyethyl, hexyl, decyl, tetradecyl, triethylene glycol methyl ether, tetraethylene glycol methyl ether and methoxybenzyl as well as -α^-Ο-Ο,,Η^-ΟΗ, -CH2-0-C6H4-0- (CH2CH20) 2-CH3, -CH2-0-C6H4-0- (CH2CH20) ^C^H^ , -CH2-0-C6H4-O-C4H8-OH, -(CH2CH20)5-CH3, - 13 - -(¼Η18-ΟΗ, -C^g-COOH, -CH2-0-C6H4-0-C6H12-COOH, -CH2-O-C6H-O-C4H8-0-CH2-CH0H-CH2OH, -CH2-O-C10H20-COOH, -CH2-0-C6H4-Cl, -CH2-0-C6H4-N02, -CH2-0-C6H3Cl2, -CH2-0-C6H4-COOH, -CH2-0-CH2-CHOH-CH2OH, -CHOH-CH2OH, -CH2-0-C6H4-0-CH2-COOH and —CH2—O—C6H4—CjH^ .
In the use of volatile epoxides, such as, e.g., ethylene oxide or propylene oxide, the reaction is performed in an autoclave.
In substrate IV, optionally present carboxyl and/or hydroxy groups are present preferably in protected form, as described above in the case of substrate III.
Another special embodiment of the process according to the invention is the production of compounds of general formula I with R meaning a -C-NHR radical, II X in which X means an oxygen or sulfur atom and R9 means a phenyl, 1- or 2-naphthyl or straight-chain or cyclic C,-C6 alkyl group, characterized in that tetraazatricyclotridecane or tetraazatricyclopentadecane is reacted with a feedstock of general formula V R9-N=C=X (V) , in which X and R have the above-indicated meaning, - 14 - with or without solvent, preferably aprotic solvents, such as, β·9·, benzene, toluene, dichloromethane, tetrahydrofuran, dioxane, acetonitrile, dimethylformamide, hexane or ether, are used as solvent, at 0°C to 180 °C, preferably room temperature to 150°C (and in the case of the higher reaction temperature, the solvent used optionally to dissolve the added feedstock of general formula V was distilled off previously in a vacuum) , within 1 to 48 hours, preferably 5 to 12 hours. The thus obtained reaction mixture is cooled to -20°C to 80°C, preferably 0°C to 30°C, mixed with a mixture of water/organic solvent, such as, e.g., methanol, ethanol, isopropanol, tetrahydrofuran or dioxane, and stirred for 0.5 to 12 hours, preferably 0.5 to 3 hours, at -20°C to room temperature, preferably 0°c to room temperature. The thus formed — optionally to be isolated —intermediate product carrying a formyl group on a nitrogen atom is reacted by adding an inorganic base such as, e.g., lithium hydroxide, sodium hydroxide, potassium hydroxide, barium hydroxide or calcium hydroxide, preferably sodium hydroxide and potassium hydroxide, or a mineral acid, such as, e.g., hydrochloric, sulfuric or hydrobromic acid, preferably hydrochloric acid, at 0°C to 150°C, preferably room temperature to 120°C, within 1 to 72 hours, preferably 6 to 24 hours, with stirring to obtain the end product of formula I, which can then be isolated in a way known in the art, preferably as hydrochloride.
Still another special embodiment of the process according to the invention is the production of compounds of general formula I with R meaning a - (CH2)2-NH-S02-R10 radical, in which R10 means a C^~C6 alkyl, -CF3 or a phenyl group optionally substituted by a C,-C6 alkyl, chlorine, bromine or nitro radical, - 15 - characterized in that tetraazatricyclotridecane or tetraazatricyclopentadecane is reacted with a feedstock of general formula VI in which R10 has the above-indicated meaning, with solvent, preferably aprotic solvents, such as, e.g. , benzene, toluene, dichloromethane, tetrahydrofuran, dioxane, acetonitrile, dimethylformamide, hexane or ether, are used as solvent, at 0°C to 180°C, preferably room temperature to 150 °C (and in the case of the higher reaction temperature, the solvent used was distilled off previously in a vacuum) , within 1 to 48 hours, preferably 5 to 12 hours. The thus obtained reaction mixture is cooled to -20°C to 80°C, preferably 0°C to 30°C, mixed with a mixture of water/organic solvent, such as, e.g. , methanol, ethanol, isopropanol, tetrahydrofuran or dioxane, and stirred for 0.5 to 12 hours, preferably 0.5 to 3 hours, at -20 °C to room temperature, preferably 0"C to room temperature. The thus formed — optionally to be isolated — intermediate product carrying a formyl group on a nitrogen atom is reacted by adding an inorganic base such as, e.g., lithium hydroxide, sodium hydroxide, potassium hydroxide, barium hydroxide or calcium hydroxide, preferably sodium hydroxide and potassium hydroxide, or a mineral acid, such as, e.g., hydrochloric, sulfuric or hydrobromic acid, preferably hydrochloric acid, at 0°C to 150°C, preferably room temperature to 120°C, within 1 to 72 hours, preferably 6 to 24 hours, with stirring to the end product of formula I, which can then be isolated in a way known in the art, preferably as hydrochloride.
Preferred radicals R0 are the phenyl radical and 4-methylphenyl radical. - 16 - Another special embodiment of the process according to the invention is the production of dimers, i.e., compounds of general formula I with R meaning a second 1,4,7,10-tetraazacyclododecane or 1, 4 , 7 , 10-tetraazacyclotetradecane molecule bound by a bis(B-hydroxy)-alkylene chain -CH,-CH-K-CH-CH,- I I OH OH in which K means a C0-C16 alkylene chain optionally substituted by 1 to 6 hydroxy, 1 to 6 C-C7 hydroxyalkyl, 1 to 8 C^-C7 alkoxy, 1 to 8 C7-C10 aralkoxy, and/or 1 to 2 benzyloxy groups, and optionally interrupted by 1 to 6 oxygen atoms, 1 to 2 phenylene, phenylenoxy or phenylenedioxy groups, and the optionally present hydroxy groups optionally are present in protected form, characterized in that tetraazatricyclotridecane or tetraazatricyclopentadecane is reacted with a feedstock of general formula VII CH,-CH-K-CH-CH, (VII) , \2/ \ / O o in which K has the above-indicated meaning, and optionally present hydroxy groups are optionally protected, with or without solvent, preferably aprotic solvents, such as, e.g., benzene, toluene, dichloromethane, tetrahydrofuran, dioxane, acetonitrile, dimethylformamide, hexane or ether, are used as solvent, at 0°C to 220°C, preferably 50°C to 180°C (and in the case of the higher reaction temperature, the solvent used optionally to dissolve the added feedstock of general formula VII was distilled off previously in a vacuum) or in an autoclave at an excess pressure of 1 to 100 atm. within 1 to 48, preferably 5 to 12 hours. The thus obtained reaction mixture is cooled to -20°C to 80°C, preferably 0° to 30°C, mixed with a mixture of water/organic solvent, such as, e.g., methanol, ethanol, isopropanol, tetrahydrofuran or dioxane, and stirred for 0.5 to 12 hours, preferably 0.5 to 3 hours, at -20°C to - 17 - room temperature, preferably 0°C to room temperature. The thus formed — optionally to be isolated — intermediate product carrying a formyl group on a nitrogen atom is reacted by adding an inorganic base such as, e.g., lithium hydroxide, sodium hydroxide, potassium hydroxide, barium hydroxide or calcium hydroxide, preferably sodium hydroxide and potassium hydroxide, or a mineral acid, such as, e.g. , hydrochloric, sulfuric or hydrobromic acid, preferably hydrochloric acid, at 0°C to 150°C, preferably room temperature to 120 "C, within 1 to 72 hours, preferably 6 to 24 hours, with stirring — optionally followed by subsequent removal of protecting groups in a way usual in the art — to obtain the end product of formula I, which can then be isolated in a way known in the art, preferably as hydrochloride.
Preferred binding links K are, for example, -C2H4- -CH2- -CH2-0-CH2- -CH2-0-CH2-CH2-0-CH2- -CH2-0- (CH2CH20) 2-CH2- -CHOH- -CHOH-CHOH- -CHOH-CHOH-CHOH- -CH2-0-CH2-CHOH-CH2-0-CH2- -CH2-0-C6H4-0-CH2- -CH2-0-C4H8-0-CH2- -C(CH2OH)2- -CH(CH2OH)- -CH2-0-C6H4-0-C6¾-0-CH2- -CHOH-CHOH-CHOH-CHOH- -CH2-0-CH2-CH (CH2OH) 2-CH2-0-CH2- -CH2-CH (CH2OCH3) -CH2- -CH(0CH3) - -CH2-0-CH2-C6H4-CH2-0-CH2- - 18 - In contrast to substrates III to VI, which — as compared with feedstock II — are reacted equimolarly to any excess, preferably with 1.05 to 2.0 equivalents, substrate VII is used in a deficiency of 0.5 to 0.3 equivalents.
In substrate VII, optionally present hydroxy groups are present preferably in protected form, as described above in the case of substrate III.
The above-described process according to the invention is distinguished by high yields, a small number of reaction steps, great variation range in desired substituents R, problem-free performance of large batches (upscaling) , partially by possible dispensing with solvent, as well as problem-free purification of the end products.
The following examples are used to explain the object of the invention in more detail.
Without further elaboration, it is believed that one skilled in the art can, using the preceding description, utilize the present invention to its fullest extent. The following preferred specific embodiments are, therefore, to be construed as merely illustrative, and not limitative of the remainder of the disclosure in any way whatsoever.
In the foregoing and in the following examples, all temperatures are set forth uncorrected in degrees Celsius and unless otherwise indicated, all parts and percentages are by weight. - 19 - E X A M P L E S Reactions with compounds of general formula Example 1 a) Mixture of 1- and 4-formamido-10- [ (2-ethoxycarbonyl) -ethyl] -1 , 4,7 , 10-tetraazacyclododecane 15.9 g (133.5 mmol) of dimethylformamide-dimethylacetal (under nitrogen) is added to 20.0 g (116.1 mmol) of 1 , 4 , 7 , 10-tetraazacyclododecane in 200 ml of absolute toluene. It is refluxed slowly and the solvent is partially distilled off in this way. Then, 13.94 g (139.2 mmol) of acrylic acid ethyl ester is instilled under a nitrogen atmosphere and heated slowly (within 30 minutes) to 80°C. It is stirred for 12 hours at this temperature. It is cooled in an ice bath to 0°C, and a mixture of 150 ml of ethanol/20 ml of water is added. Then, it is stirred for 30 minutes at room temperature. It is evaporated to dryness in a vacuum and the residue is chromatographed on silica gel (mobile solvent = ethanol/conc. aqu. ammonia = 10/1) . After concentration by evaporation of the main fractions, 31.71 g (91% of theory) of a yellowish oil is obtained.
Analysis (relative to the anhydrous substance) : Cld: C 55.98 H 9.39 N 18.65 Fnd: C 55.91 H 9.43 N 18.59 b) 10- (2-Carboxyethyl) -1,4,7 , 10-tetraazacyclododecane 46.32 g (825.6 mmol) of potassium hydroxide is added to 31.0 g (103.2 mmol) of the title compound of example la in 150 ml of ethanol/150 ml of water and refluxed for 12 hours. It is cooled in an ice bath to 0°C. It is adjusted with 6N hydrochloric acid to pH 6 and then concentrated by evaporation in a vacuum. The residue is extracted with a mixture of 300 ml of methanol/50 ml of methylene chloride and filtered off from potassium chloride. The filtrate is concentrated by evaporation in a vacuum and purified on a reversed-phase column (RP 18/mobile solvent: gradient of tetrahydrofuran/water) .
Yield: 23.02 g (87% of theory) of a yellowish, viscous oil, which solidifies after a short time Analysis (relative to the anhydrous substance) : Cld: C 56.23 H 9.44 N 21.86 Fnd: C 56.17 H 9.51 N 21.83 Example 2 10- (2-Cyanoethyl) -1, 4 ,7 , 10-tetraazacyclododecane 15.9 g (133.5 mmol) of dimethylformamide-dimethylacetal (under nitrogen) is added to 20.0 g (116.1 mmol) of 1, 4 , 7 , 10-tetraazacyclododecane in 200 ml of absolute toluene. It is refluxed slowly and the solvent is distilled off in this way. Then, it is concentrated by evaporation under reduced pressure. The residue is cooled to room temperature. 9.24 g (174.15 mmol) of acrylic acid nitrile is instilled under a nitrogen atmosphere and heated slowly to 75 °C. It is stirred for 9 hours at this temperature. It is cooled to room temperature and a mixture of 120 ml of methanol/30 ml of water is added. It is stirred for 10 minutes at room temperature. Then, 13.93 g (348.3 mmol) of sodium hydroxide is added and it is stirred for 24 hours at 40 °C. It is evaporated to dryness in a vacuum and the residue is extracted 3 times with hot toluene (80°C) . The organic phase is dried on potassium hydroxide and concentrated by evaporation in a vacuum.
Yield: 23.28 g (89% of theory) of a pale yellow oil, which crystallizes with standing.
Analysis (relative to the anhydrous substance) : Cld: C 58.63 H 10.29 N 31.08 Fnd: C 58.57 H 10.34 N 30.96 Example 3 10 - [ (2-Phenyl-2-carboxy) -ethyl] - 1 , 4,7 , 10-tetraazacyclododecane 15.9 g (133.5 mmol) of dimethylformamide-dimethylacetal (under nitrogen) is added to 20.0 g (116.1 mmol) of 1,4,7,10-tetraazacyclododecane in 200 ml of absolute toluene. It is refluxed slowly and the solvent is distilled off in this way. Then, it is concentrated by evaporation under reduced pressure. The residue is cooled to room temperature. 24.55 g (139.32 ol) of 2-phenyl-vinyl acid ethyl ester is instilled under a nitrogen atmosphere and slowly heated to 130 °C. It is stirred for 12 hours at this temperature. It is cooled to room temperature and a mixture of 150 ml of methanol/150 ml of water is added. Then, it is stirred for 30 minutes at room temperature. 52.11 g (928.8 mmol) of potassium hydroxide is added and refluxed for 12 hours. It is cooled in an ice bath to 00C and adjusted with cone, hydrochloric acid to pH 7, then evaporated to dryness. The residue is taken up in a mixture of 250 ml of methanol/50 ml of methylene chloride. The precipitated potassium chloride is filtered off and the filtrate is concentrated by evaporation in a vacuum. The residue is chromatographed on silica gel (mobile solvent = methyl-tert-butyl ether/methanol/conc. agu. ammonia = 6/2/1) .
Yield: 28.27 g (76% of theory) of a vitreous solid Analysis (relative to the anhydrous substance) : Cld: C 63.72 H 8.81 N 17.48 Fnd: C 63.64 H 8.93 N 17.37 Example 4 11- (2-Cyanoethyl) -1, 4 ,8 , ll-tetraazacyclotetradecane 13.68 g (114.8 mmol) of dimethylformamide-dimethylacetal (under nitrogen) is added to 20.0 g (99.83 mmol) of 1, 4 , 8 , ll-tetraazacyclotetradecane in 200 ml of absolute toluene. It is refluxed slowly and the solvent is - 22 - distilled off in this way. Then, it is concentrated by evaporation under reduced pressure. The residue is cooled to room temperature. 6.36 g (119.8 mmol) of acrylic acid nitrile is instilled under a nitrogen atmosphere and heated slowly to 75 °C. It is stirred for 9 hours at this temperature. It is cooled to room temperature and a mixture of 120 ml of methanol/30 ml of water is added. It is stirred for 10 minutes at room temperature. Then, 11.98 g (299.5 mmol) of sodium hydroxide is added and it is stirred for 24 hours at 40 °C. It is evaporated to dryness in a vacuum and the residue is extracted 3 times with hot toluene (80°C). The organic phase is dried on potassium hydroxide and concentrated by evaporation in a vacuum.
Yield: 21.75 g (86% of theory) of a pale yellow oil, which crystallizes with standing Analysis (relative to the anhydrous substance) : Cld: C 61.62 H 10.74 N 27.64 Fnd: C 61.53 H 10.84 N 27.52 For example, the compounds listed in the following table are produced analogously. - 23 - Table la Key: Temp. (°C)/Zeit (h) = temp. ( °C) /time (h) Loesungsmittel = solvent Ueberschuss (Aiken) = excess (alkene) Ausbeute (%) = Yield (%) Elementaranalyse = elementary analysis (ber.) = (cld) Temp . (°C) Losungs- Uberschuft Ausbeute R E 1 emen teranalyae Zeit (h) mi 11e 1 (Aiken) (¾) 100 °C 1 , 2 87 C 57, 30 H 9 ,62 N 17,82 (ber ) 12 - c 57,35 H 9.58 N 17,87 120 °C 1 , 3 92 c 4.82 H 8,66 N 15 ,04 (ber. ) 12 h - c 54,73 H 8,71 N 14,97 ( ber. ) (ber. ) 100 °C 1.2 93 c 53.11 H 9.29 N 25.81 (ber. ) 24 h - c 53,20 H 9 ,21 N 25,74 - 24 - Table lb Key; Base/Loesungsmittel = base/solvent Ueberschuss Base (eq.) = excess base (eq Zeit (h) = time (h) Ausbeute (%) = yield (%) Elementaranalyse = elementary analysis Rueckfluss = reflux (ber.) = (cld) <— T a b e 1 1 e lb Base/ Uber schuB Temp . Zeit Auabeute R Lbeunga- Base Elementaranalyse <°C) (h) (S) mittel (oq.) KOH 0 Riickf luil 12 83 C 57,75 H 9,69 N 20, 72 (ber. ) eOH/H20 1 : 1 c 57,68 H 9,78 N 20, 67 KOH 10 Ruckflun 2 79 c ¾9,99 H 8,39 N 19, ¾3 (ber. ) EtOH/H20 1 :1 c Ί9.90 H 8.Ί6 N 19,37 @ KOH 8 Riickflun 12 85 c 63.72 H 8,81 N 17, ¾8 (ber. ) Ma.OH/H20 1 : 1 c 63,65 H 8,87 17,39 KOH 8 50 °C 2Ί 79 c 55.88 H 7,¾5 N 19, 16 (ber. ) MeOH/H20 1 : 1 c 55, 8¾ H 7,52 N 19,08 ^A^, NaOH j 3 RT 2k 89 c 5¾.29 H 10, 35 N 28, 70 ( bar . ) MeOH/H20 Ί : 1 c 5<«,23 H 10,29 N 28,81 - 25 - Reactions with compounds of general formula IV: Example 5 a) Mixture of l- and 4-formamido-10- ( 6-hydroxy-2/2-dimethyl-l,3-dioxepan-5-yl) -l, 4 ,7 , 10-tetraazacyclododecane 15.9 g (133.5 mmol) of dimethylformamide-dimethylacetal (under nitrogen) is added to 20.0 g (116.1 mmol) of 1, 4 , 7 , 10-tetraazacyclododecane in 200 ml of absolute toluene. It is refluxed slowly and the solvent is partially distilled off in this way. Then,, 20.1 g (139.32 mmol) of 4 , 4-dimethyl-3 , 5, 8-trioxabicyclo- (5.1.0) -octane is instilled under a nitrogen atmosphere and heated slowly (1 hour) to 130 °C. It is stirred for 12 hours at 120 °C. It is cooled to room temperature and a mixture of 120 ml of methanol/30 ml of water is added. Then, it is stirred for one hour at room temperature. It is concentrated by evaporation in a vacuum and the residue is chromatographed on silica gel (mobile solvent = methyl-tert-butyl ether/methanol/aqu. cone. ammonia = 15/5/1) . After concentration by evaporation of the main fractions, 36.39 g (91% of theory) of a pale yellow, viscous oil, which crystallizes with standing, is obtained.
Analysis (relative to the anhydrous substance) : Cld: C 55.79 H 9.36 N 16.27 Fnd: C 55.82 H 9.29 N 16.20 b) 10- ( 6-Hydroxy-2 , 2-dimethyl-l , 3-dioxepan-5-yl) -1,4,7, 10-tetraazacyclododecane 57.0 g (1.02 mol) of potassium hydroxide is added to 35.0 g (101.6 mmol) of the title compound of example 5a in 200 ml of methanol/50 ml of water and refluxed for 5 hours. It is evaporated to dryness in a vacuum and the residue is extracted 3 times with 200 ml of hot (80°C) toluene. The organic phase is dried on potassium hydroxide and concentrated by evaporation in a vacuum.
Yield: 31.5 g (98% of theory) of a pale yellow, viscous oil, which becomes solid with standing Analysis (relative to the anhydrous substance) : Cld: C 56.93 H 10.19 N 17.71 Fnd: C 56.87 H 10.25 N 17.63 Example 6 a) Mixture of 1- and 4-formamido-10- (2-hydroxypropyl) -1/4,7, 10-tetraazacyclododecane 15.9 g (133.5 mmol) of dimethylformamide-dimethylacetal (under nitrogen) is added to 20.0 g (116.1 mmol) of 1, 4 , 7 , 10-tetraazacyclododecane in 200 ml of absolute toluene. It is refluxed slowly and the solvent is distilled off in this way. Then, it is concentrated by evaporation under reduced pressure. The residue is cooled to 0°C. The residue is dissolved in 50 ml of toluene and the solution is fed into an autoclave. 20.23 g (348.3 mmol) of propylene oxide is added and the autoclave is made airtight. Then, it is heated for 24 hours to 100°C. It is evaporated to dryness in a vacuum and the residue is taken up in a mixture of 120 ml of methanol/30 ml of water. Then, it is stirred for one hour at room temperature. It is concentrated by evaporation in a vacuum and the residue is chromatographed on silica gel. (Mobile solvent = methanol/isopropanol/aqu. cone, ammonia = 10/5/1) . After concentration by evaporation of the main fractions in a vacuum, 26.7 g (89% of theory) of a weak, yellow-colored oil is obtained.
Analysis (relative to the anhydrous substance) : Cld: C 55.79 H 10.14 N 21.69 Fnd: C 55.72 H 10.19 N 21.61 b) 10- (2-Hydroxypropyl) -1,4,7/ 10-tetraazacyclododecane 45.2 g (805.1 mmol) of potassium hydroxide is added to 26.0 g (100.63 mmol) of the title compound of example 6a in 250 ml of water and refluxed for 5 hours. It is evaporated to dryness in a vacuum and the residue is extracted 3 times with 200 ml of hot (80°C) toluene. The organic phase is dried on potassium hydroxide and concentrated by evaporation in a vacuum.
Yield: 22.02 g (95% of theory) of a weak, yellowish oil, which solidifies after a short time Analysis (relative to the anhydrous substance) : Cld: C 57.36 H 11.38 N 24.32 Fnd: C 57.30 H 11.43 N 24.28 Example 7 10-[2-Hydroxy-5-(2,2-dimethyl-l,3-dioxolan-4-yl)-4-oxapentyl] -1 , 4,7, 10-tetraazacyclododecane 15.9 g (133.5 mmol) of dimethylformamide-dimethylacetal (under nitrogen) is added to 20.0 g (116.1 mmol) of 1, 4 , 7 , 10-tetraazacyclododecane in 200 ml of absolute toluene. It is refluxed slowly and the solvent is distilled off in this way. Then, it is concentrated by evaporation under reduced pressure. The residue is cooled to 40°C. 24.04 g (127.7 mmol) of 2 , 2-dimethyl-4- (2 ■ , 31 -epoxy) -propoxy-methyl-l, 3-dioxolane is instilled under a nitrogen atmosphere and heated slowly (within one hour) to 110°C. It is stirred for 12 hours at this temperature. It is cooled to room temperature and a mixture of 120 ml of methanol/30 ml of H20 is added. Then, it is stirred for 30 minutes at room temperature. 65.1 g (1.16 mol) of potassium hydroxide is added and refluxed for 5 hours. Then, it is concentrated by evaporation in a vacuum and the residue is extracted 3 times with 200 ml of hot toluene (80 °C) . The combined organic phases are dried on potassium hydroxide and evaporated to dryness in a vacuum. The residue is chromatographed on silica gel (mobile solvent = - 28 - methanol/water/aqu. cone, ammonia = 8/2/1) . The main fractions are evaporated to dryness, the residue is dissolved in 500 ml of hot toluene. It is filtered off from insolubles (silica gel) and evaporated to dryness.
Yield: 36.41 g (87% of theory) of a pale yellow, viscous oil Analysis (relative to the anhydrous substance) : Cld: C 56.64 H 10.07 N 15.54 Fnd: C 56.53 H 10.13 N 15.49 Example 8 10- [3- (4-Nitrophenoxy) -2 -hydroxy ropyl ] -1,4,7,10-tetraazacyclododecane (as tetrahydrochloride) 15.9 g (133.5 mmol) of dimethylformamide-dimethylacetal (under nitrogen) is added to 20.0 g (116.1 mmol) of 1 , 4 , 7 , 10-tetraazacyclododecane in 200 ml of absolute toluene. It is refluxed slowly and the solvent is distilled off in this way. Then, it is concentrated by evaporation under reduced pressure. The residue is cooled to room temperature. A solution of 29.46 g (150.93 mmol) of (4-nitrophenyl) -2 , 3-epoxypropyl ether in 100 ml of methylene chloride is instilled under a nitrogen atmosphere. Then, it is heated slowly to 120 °C, and the methylene chloride is distilled off (toward the end under reduced pressure) . It is stirred for 12 hours at 120 °C. It is cooled to room temperature and a mixture of 160 ml of methanol/20 ml of water is added. Then, it is stirred for 30 minutes at room temperature. 50 ml of cone, hydrochloric acid is added and refluxed for 12 hours. Then, it is evaporated to dryness in a vacuum. The residue is recrystallized from methanol/ether.
Yield: 48.27 g (81% of theory) of a yellow-colored crystalline powder Analysis (calculated for a Cl-free compound) : Cld: C 55.57 H 7.95 N 19.06 Fnd: C 55.49 H 8.03 N 19.01 Example 9 a) 11- [3- (4-Nitroxyphenoxy) -2-hydroxypropyl] -1,4,8, 11-tetraazacyclotetradecane (as tetrahydrochloride) 13.68 g (114.8 mmol) of dimethylformamide-dimethylacetal (under nitrogen) is added to 20.0 g (99.83 mmol) of 1,4,8,11-tetraazacyclotetradecane in 200 ml of absolute toluene. It is refluxed slowly and the solvent is distilled off in this way. Then, it is concentrated by evaporation under reduced pressure. The residue is cooled to room temperature. A solution of 23.38 g (119.8 mmol) of (4-nitrophenyl) -2 , 3-epoxypropyl ether in 100 ml of methylene chloride is instilled under a nitrogen atmosphere. Then, it is heated slowly to 120 °C, and the methylene chloride is distilled off (toward the end under reduced pressure) . It is stirred for 12 hours at 120 °C. It is cooled to room temperature and a mixture of 150 ml of methanol/20 ml of water is added. Then, it is stirred for 30 minutes at room temperature. 100 ml of cone, hydrochloric acid is added and refluxed for 12 hours. Then, it is evaporated to dryness in a vacuum. The residue is recrystallized from methanol/ether.
Yield: 41.61 g (77% of theory) of a yellowish, crystalline powder.
Analysis (relative to the anhydrous substance) : Cld: C 42.16 H 6.89 N 12.94 CI 26.20 Fnd: C 42.10 H 6.93 N 12.90 Cl 26.08 Example 10 a) Mixture of 1- and 4- and 8-formamido-li- [2-hydroxy-2-(2,2-dimethyl-l, 3-dioxolan-4-yl ) -ethyl]-l,4,8,ll-tetraazacyclotetradecane 13.68 g (114.8 mmol) of dimethylformamide-dimethylacetal (under nitrogen) is added to 20.0 g (99.83 mmol) of 1, 4 , 8 , 11-tetraazacyclotetradecane in 200 ml of absolute toluene. It is refluxed slowly and the solvent is distilled off in this way. Then, it is concentrated by - 30 - evaporation under reduced pressure. The residue is cooled to room temperature. 17.27 g (119.8 mmol) of 2- (2 , 2-dimethyl-l, 3-dioxolan-4-yl) -ethylene oxide is instilled under a nitrogen atmosphere and then heated slowly to 130°C. It is stirred for 12 hours at this temperature. It is cooled to 0°C and a mixture of 160 ml of methanol/40 ml of water is added, then it is stirred for 1 hour at room temperature. It is evaporated to dryness in a vacuum and the residue is chromatographed on silica gel (mobile solvent = methyl-tert-butyl ether/methanol/conc. aqu. ammonia = 15/5/1) .
Yield: 33.1 g (89% of theory) of a pale yellow, viscous oil Analysis (relative to the anhydrous substance) : Cld: C 58.04 H 9.74 N 15.04 Fnd: C 58.13 H 9.61 N 14.92 b) 11- [2-Hydroxy-2- (2 , 2-dimethyl-l, 3-dioxolan-4-yl) -ethyl]-l 4/8 11-tetraazacyclotetradecane 39.15 g (698 mmol) of potassium hydroxide is added to 32.0 g (87.22 mmol) of the title compound of example 10a in 200 ml of methanol/100 ml of water and refluxed for 5 hours. It is evaporated to dryness in a vacuum and the residue is extracted 3 times with 200 ml of hot toluene (80 °C) . The organic phase is dried on potassium hydroxide and concentrated by evaporation in a vacuum.
Yield: 28.85 g (96% of theory) of a pale yellow, viscous oil, which solidifies after a short time Analysis (relative to the anhydrous substance) : Cld: C 59.27 H 10.53 N 16.26 Fnd: C 59.18 H 10.61 N 16.17 For example, the compounds listed in the following table are produced analogously. - 31 - Table 2a Key; Zeit (h) = time (h) Loesungsitiittel = solvent Ueberschuss (Epoxid) = excess (epoxide) Ausbeute (%) = yield (%) Elementaranalyse = elementary analysis (ber.) = Cld (Fortsetzung) = (continuation) Ueberschuss (Aiken) = excess (alkene) ϊοπιρ . ( °C ) Losungf Oborachufi Λυ a b ou t o R Elomontora Zoit (h) m i t t c 1 (Epoxid) (.%) 120 °C 1 , 1 91 c 6l ,69 11 0,63 ^-o^ 0 h - c 6 i , 6 i II 0,67 120 "C 1 , 1 90 c 6 ?. , 6 l II 0 , (15 0 c 62, 6Ί 11 0,00 59,90 H 0,'ιδ 8 h CH2C12 59,09 H 0,53 ( Fortsotzung) T o b o 1 1 o 2o Temp. ( C) Loaungs- Ubcrachuli Auabouto E lcino Zeit ( ) niittoi (A Ikon) 1 , 1 93 C 56,93 U 10, n h C 55 , 86 II 10, 1 0 c * V V 59 ,97 Π 10.
U h C 59, II 10 , 1 , 2 07 C 62, 1 Ί H 10, 12 h c 62,03 li 10, - 34 - Table 2b Key: Base/Loesungsntittel = base/solvent Ueberschuss Base (eq.) = excess base (eq. ) Zeit (h) = time (h) Ausbeute (%) = yield (%) Elementaranalyse = elementary analysis Rueckfluss = reflux (ber.) = (cld) (Fortsetzung) = (continuation) Base/ Ub e r schufi Temp . Zcit Ausbeute Lbaungs- Base Eleme (°C) (h) mittol < eq.) KOH 10 nUckf lufi 97 C 56,93 II 10, MeOH/H 0 Ί : 1 C 56 , 00 H 10, NoOH 63,32 H 9, KtOK/Κ,,Ο 5 : 1 63,20 H 9 , NaOH 60 °C 2Ί 98 C 6Ί.25 H 9, EtOH/H20 5; ! C 6Ί, \ 't H 9, KOH 57,21 H 0, EtOH/H 0 8: 1 57, 1'i H 8, ( Fortsotzung ) n b e 1 1 c 2b B os o/ Ubor schuft Temp . Z a I t Ausbeut o Lb sung s - U a a e (°C) ( ) (54) mittol q.) NaOH nUckf lufl 98 C 58, 30 MoOH/ll20 Ί : 1 C 5θ,2'ι KOH 10 Uuclif l li 98 c 61 , 72 E tOlf/H b : 1 C 61 ,67 KOH 10 Ruckflufl 97 C 63 , 6 Ί EtOH/HgO 'ii1 C 63 , 5 k . KOH 30 C ka 93 C 61 , 7'i ,ΕΐΟΗ/Η,,Ο k : 1 C 61 , 66 Reactions with compounds of general formula V: R9-N=C=X Example 11 10- (N-Phenylcarbamoyl) -1,4,7 , 10-tetraazacyclododecane 15.9 g (133.5 mmol) of dimethylformamide-dimethylacetal (under nitrogen) is added to 20.0 g (116.1 mmol) of 1,4,7, 10-tetraazacyclododecane in 200 ml of absolute toluene. It is refluxed slowly and the solvent is distilled off in this way. Then, it is concentrated by evaporation under reduced pressure. The residue is cooled to 0°C. 16.6 g (139.32 mmol) of phenyl isocyanate is instilled under a nitrogen atmosphere and heated slowly to 100 °C. It is stirred for 12 hours at this temperature. It is cooled to room temperature and a mixture of 160 ml of ethanol/40 ml of water is added. Then, it is stirred for 10 minutes at room temperature. Then, 18.58 g (464.4 mmol) of sodium hydroxide is added and it is stirred for 24 hours at 40 °C. It is evaporated to dryness in a vacuum and the residue is taken up in 400 ml of water. The aqueous phase is extracted 5 times with 200 ml of methylene chloride, the organic phase is dried on magnesium sulfate and concentrated by evaporation in a vacuum. The residue is chromatographed on silica gel (mobile solvent = methyl-tert-butyl ether/methanol/conc. aqu. ammonia = 6/3/1) .
Yield: 29.1 g (86% of theory) of a pale yellow solid Analysis (relative to the anhydrous substance) : Cld: C 61.83 H 8.65 N 24.03 Fnd: C 61.71 H 8.72 N 23.94 For example, the compounds listed in the following table are produced analogously. - 38 - Table 3a Key: Zeit (h) = time (h) Loesungsmittel = solvent Ueberschuss (eq. ) (Acyl-Reagenz) = excess (eq.) (acyl reagent) Ausbeute (%) = yield (%) Elementaranalyse = elementary analysis (ber.) = (cld) Temp. ( °C ) Loflunga- Uberachud Auaboute E lamen Z.it (h) mittol , ( A .cyl ,- „Reqajonz ,) (S) ioo 1 ,2 93 C 59,05 H 9,60 2 C 59, 1Ί H 9,53 100 "C 1 , 2 O 65,02 H 7,37 lO C 65 , 11 H , 30' 100 c 1.1 90 57,29 H 7,51 12 (1 57,20 H 7,60 100 °c 87 C 62, 31 H 7,06 ifl h C,I2C12 C 62, 35 II 7,01 - 39 - Table 3b Key: Base/Loesungsmittel = base/solvent Ueberschuss Base (eq.) = excess base (eq.) Zeit (h) = time (h) Ausbeute (%) = yield (%) Elementaranalyse = elementary analysis (ber.) = (cld) T n b o l l o b Ooao/ Ubersc uH Temp. Zoit Auabouto Lbaunga- Uaac Elementa (°C) (h) (S) mittol (eq. ) NaOll 60,57 H 10,50 -o EtOH/H20 ¾ : 1 60, ¾8 H 10,58 NaOll C 66 , 80 II 7 , 97 EtOII/ll_0 8 C 66 , 78 H 7,93 NaOH C 58,60 H 8,20 E tOH/H 0 C 58,63 H 8, 29 NaOH Ί0 2Ί 96 C 63,83 H 7,61 EtOH/H20 8: 1 C .63,78 H 7,55 - 40 Reactions with a compound of general formula VI: Example 12 a) Mixture of 1- and 4-formamido-10- [2- (p-tolylsulfonylamino) -ethyl] -1, 4 ,7 , 10-tetraazacyclododecane 15.9 g (133.5 mmol) of dimethylformamide-dimethylacetal (under nitrogen) is added to 20.0 g (116.1 mmol) of 1,4,7, 10-tetraazacyclododecane in 200 ml of absolute toluene. It is refluxed slowly and the solvent is distilled off in this way. Then, it is concentrated by evaporation under reduced pressure. The residue is cooled to 0°C. A solution of 25.19 g (127.71 mmol) of p-tolylsulfonyl aziridine in 100 ml of toluene is instilled under a nitrogen atmosphere and then stirred for 8 hours at 80 °C. It is evaporated to dryness in a vacuum and the residue is taken up in a mixture of 180 ml of ethanol/30 ml of water. Then, it is stirred for 30 minutes at room temperature. Then, it is evaporated to dryness. The residue is chromatographed on silica gel (mobile solvent = methyl-tert-butyl ester/methanol/conc. aqu. ammonia = 6/2/1) .
Yield: 40.61 g (88% of theory) of a vitreous solid Analysis (relative to the anhydrous substance) : Cld: C 54.38 H 7.86 N 17.62 S 8.06 Fnd: C 54.31 H 7.93 N 17.58 S 7.99 b) 10-[2-(p-Tolylsulfonylamino)-ethyl]-l, 4,7, 10-tetraazacyclododecane 20.12 g (503 mmol) of sodium hydroxide is added to 40.0 g (100.62 mmol) of title compound 9a in 180 ml of ethanol/30 ml of water and refluxed for 12 hours. It is evaporated to dryness and the residue is taken up in 100 ml of water. The pH of the solution is brought to pH 10 by adding 6N hydrochloric acid. Then, it is extracted twice with 250 ml of hot toluene (80 °C) . The organic phase is dried on magnesium sulfate and concentrated by evaporation in a vacuum.
Yield: 36.07 g (97% of theory) of a yellowish, vitreous solid Analysis (relative to the anhydrous substance) : Cld: C 55.26 H 8.46 N 18.95 S 8.68 Fnd: C 55.21 H 8.52 N 18.90 S 8.59 c) Mixture of 1- and 4-formamido-10- [2-(methylsulfonylamino) -ethyl] -1, ,7 , 10-tetraazacyclododecane Analogously to example 12a, methylsulfonyl aziridine can be used instead of p-tolylsulfonyl aziridine.
Yield: 89% of theory Analysis (relative to the anhydrous substance) : Cld: C 44.84 H 8.47 N 21.79 S 9.97 Fnd: C 44.76 H 8.53 N 21.73 S 9.90 d) 10- [2- (methylsulfonylamino) -ethyl] -1,4,7,10-tetraazacyclododecane Analogously to example 12b, the title compound of example 12c can be used instead of title compound 12a.
Yield: 96% of theory Analysis (relative to the anhydrous substance) : Cld: C 45.03 H 9.27 N 23.87 S 10.93 Fnd: C 44.96 H 9.34 N 23.98 S 10.85 - 42 - Reactions with compounds of general formula VII: CH2-CH-K-CH-CH2 w \ / o o Example 13 a) Mixture of the bis-formamides of 1,1 · - (2 , 6-dihydroxy-4-oxa-1, 7-heptyl) -bis- [1,4,7, 10-tetraazacyclododecane 15.9 g (133.5 mmol) of dimethylformamide-dimethylacetal (under nitrogen) is added to 20.0 g (116.1 mmol) of 1, 4 , 7 , 10-tetraazacyclododecane in 200 ml of absolute toluene. It is refluxed slowly and the solvent is distilled off in this way. Then, it is concentrated by evaporation under reduced pressure. The residue is cooled to 40°C. 7.25 g (55.7 mmol) of bis- [2 , 3-epoxypropyl ] -ether is instilled under a nitrogen atmosphere and heated slowly to 120 °C. It is stirred for 24 hours at this temperature. It is cooled to room temperature and a mixture of 200 ml of methanol/100 ml of water is added. Then, it is stirred for one hour at room temperature. It is evaporated to dryness and the residue is chromatographed on silica gel (mobile solvent = methanol/isopropanol/conc. aqu. ammonia = 8/2/1) . Yield: 18.63 g (63% of theory) of a vitreous solid Analysis (relative to the anhydrous substance) : Cld: C 54.32 H 9.50 N 21.11 Fnd: C 54.25 H 9.57 N 21.18 b) 1 , 1 ' - (2 , 6-Dihydroxy-4-oxa-l , 7-heptyl ) -bis- (1,4,7, 10-tetraazacyclododecane) 28.55 g (508.7 mmol) of potassium hydroxide is added to 18.0 g (33.92 mmol) of the title compound of example 13a in 200 ml of methanol/100 ml of water and refluxed for 2 hours. It is evaporated to dryness in a vacuum and the residue is extracted 3 times with 200 ml of hot toluene (80 °C) . The organic phase is dried on potassium hydroxide and concentrated by evaporation in a vacuum. - 43 - Yield: 15.62 g (97% of theory) of a pale yellow, viscous oil, which solidifies with standing.
Analysis (relative to the anhydrous substance) : Cld: C 55.67 H 10.62 N 23.61 Fnd: C 55.61 H 10.68 N 23.56 For example, the compounds listed in the following table are produced analogously. - 44 - Table 4a Key: Zeit (h) = time (h) Loesungsmittel = solvent Equivalent Diepoxid = equivalent diepoxide Ausbeute (%) (bezgl. Diepoxid) = yield (%) (relative to diepoxide) Elementaranalyse = elementary analysis (ber.) = (cld) = phenyl omp. (°C) sungs- Equivolorit Ausboute ( % ) Elemon Zeit (h) ittol Diopoxid ( czgl .Uiopoxid) 120 C , Ί 9 1 55, OU II 9,5 2'i h 55 , 13 II 9,5 120 "C 0 , Ί 60 C 55 ,79 H 9,7 2'i h C 55,71 H 9,7 120 °C 0 , Ί5 59 C 59, 8 H 8, 9 12 li c 59, 31 H 9,0 M; 130 °C 0 , Ί5 c 55,27 H 9,2 12 h c 55,21 H 9, 3 130 "c 0 , Ί9 61 C 57,86 H 0,7 »-< >-< 2h h CH2C12 c 57,79 H 8,6 - 46 - Table 4b Key: Base/Loesungsmittel = base/solvent Ueberschuss Base (eq.) = excess base (eq.) Zeit (h) = time (h) Ausbeute (%) = yield (%) Elementaranalyse = elementary analysis Rueckfluss = reflux (ber.) = (cld) = phenyl Base/ ersc u!) Temp . Zoit Auabeute Loeungs- Dose El ( °C ) ( ) (#) πι i 11 o 1 ( eq. ) OH 15 97 55 , 57 H MeOH/H20 2: 1 55 , 50 H OII 15 Hiickriuft Ί0 6 c 56 , 36 II 1 MoO!l/l!20 2 : 1 c 56 , 1 II KOH 15 niickf lull Ί0 98 C 57 , 1 1 H Mo0ll/H20 2 : 1 c 57 , 0Ί 11 KOH 15 Iluckf lu!i 2'l 97 c 61 , 06 H E tOH/HgO 3 : 1 c 61 ,01 H KOH 15 RiickfluQ Ί8 98 C 59 , 3'" H EtOH/H20 3 : 1 C 59 , 28 H The preceding examples can be repeated with similar success by substituting the generically or specifically described reactants and/or operating conditions of this invention for those used in the preceding examples.
From the foregoing description, one skilled in the art can easily ascertain the essential characteristics of this invention, and without departing from the spirit and scope thereof, can make various changes and modifications of the invention to adapt it to various usages and conditions.
Claims (8)
1. Process for the production of mono-N-substituted tetraazacyclododecane and tetraazacyclotetradecane derivatives of general formula I: in which: n stands for the numbers 2 or 3; R stands for a β-carboxy alkyl or β-alkoxycarbonyl alkyl, β-cyanide alkyl, β-carboxamido alkyl, β-hydroxy alkyl, aminocarbonyl, aminothiocarbonyl, β-sulfamoylalkyl radical or for a second tetraazacyclododecane or tetraazacyclotetradecane molecule bound by a bis^-hydroxy)-alkylene chain, wherein "alkyl" in β-carboxy alkyl, β-alkoxycarbonyl alkyl, β-cyanide alkyl, and β-carboxamido alkyl stands for -CR^-CHR1-; "amido" in β-carboxamido alkyl stands for CONR5R6; "alkyl" in β-hydroxy alkyl stands for -CHR7CHR8-; "amino" in aminocarbonyl and aminothiocarbonyl stands for X 50 103,996/ 2 (with X in the meaning of an oxygen or sulfur atom), "sulfamoyl" in β-sulfamoylalkyl stands for -NHS02R10; and "alkylene" in bis(P- hydroxy)-alkylene stands for K; R1 stands for a hydrogen atom, a straight-chain or cyclic Ci-C6 alkyl, a phenyl or benzyl group in which the phenyl or benzyl group can be substituted respectively by 1 to 2 chlorine, bromine, nitro, CrC alkoxy, C7-Ci0 aralkoxy and/or CO2R4 radicals, with R4 meaning a hydrogen atom, a Ci.C6 alkyl, phenyl or benzyl group; R2 and R3, independent of one another, each stand for R1 or a CO2R4 group; R5 and R6, independent of one another, each stand for a hydrogen atom, a saturated or unsaturated, straight-chain, branched-chain or cyclic hydrocarbon radical with up to 16 carbon atoms optionally interrupted by 1 to 8 oxygen atoms or 1 to 3 phenylene or phenylenoxy groups, and optionally substituted by 1 to 5 hydroxy groups or 1 to 2 CO2R4 radicals; for phenyl or benzyl radicals optionally substituted by 1 to 3 hydroxy or Ci-C6 alkoxy groups; or R5 and R6 together with the nitrogen atom stand for a saturated or unsaturated, 5- or 6-ring oxygen, sulfur atom or carbonyl group optionally containing another nitrogen, which optionally is substituted by 1 to 3 Ci-C6 alkyl radicals optionally substituted by 1 to 3 hydroxy radicals, and optionally present hydroxy and/or carboxyl groups optionally are protected; R7 and R8, independent of one another, respectively stand for a hydrogen atom, a CrC20 alkyl radical, optionally interrupted by 1 to 10 oxygen atoms, a phenylene, phenylenoxy or phenylenedioxy group, which optionally is substituted by 1 to 3 CrC6 alkyl, 1 to 3 trifluoromethyl, 1 to 7 hydroxy, 1 to 3 CrC7 alkoxy, 1 to 3 C7-C10 aralkoxy, 1 to 2 CO2R4 and/or 1 to 2 phenoxy or phenyl groups optionally substituted by 1 to 2 chlorine, 51 103,996/ 2 bromine, nitro or CrC6 alkoxy radicals, and the optionally present hydroxy radicals optionally are present in protected form; R9 stands for a phenyl, 1 or 2 naphthyl or straight-chain or cyclic CrC6 alkyl group; R10 stands for a Ci-C6 alkyl, -CF3 or a phenyl group optionally substituted by a Ci-C6 alkyl, chlorine, bromine, or nitro radical; K stands for a C0-Ci6 alkylene chain optionally substituted by 1 to 6 hydroxy, 1 to 6 CrC7 hydroxyalkyl, 1 to 8 CrC7 alkoxy, 1 to 8 C7-Ci0 aralkoxy and/or 1 to 2 benzyloxy groups, and optionally interrupted by 1 to 6 oxygen atoms, 1 to 2 phenylene, phenylenoxy or phenylenedioxy groups; and wherein carboxyl and hydroxy groups are present optionally in protected form; characterized in that the compounds of general formula II obtained from 1,4,7,10-tetraazacyclododecane or 1,4,8,11-tetraazacyclotetradecane are reacted with an α,β-unsaturated ester, amide or nitrile, or an epoxide, isocyanate, isothiocyanate, aziridine or a bisepoxide, with or without solvent, at 0-220°C, preferably room temperature to 210°C, within 1 to 48 hours, preferably 5 to 12 hours, optionally at a pressure up to 100 atm; then the thus-obtained reaction mixture, after cooling to -20-80°C, preferably 0-30°C, is mixed with a mixture of water/organic solvent and stirred 52 103,996/ 2 for 0.5-12 hours, preferably 0.5-3 hours at -20°C to room temperature, preferably 0°C to room temperature; then the thus-formed, optionally to be isolated, intermediate products carrying a formyl group on a nitrogen atom are reacted by adding an inorganic base or an acid at 0-150°C, preferably room temperature to 120°C, within 1 to 72 hours, preferably 6 to 24 hours, with stirring, optionally followed by subsequent removal of protecting groups in a way usual in the art, to obtain the end product of formula I, which can then be isolated in a way known in the art, preferably as hydrochloride.
2. A process according to claim 1, for the production of compounds of general formula I with R meaning a -A group, R3 in which: R1 stands for a hydrogen atom, a straight-chain or cyclic Cj-C6 alkyl, a phenyl or benzyl group in which the phenyl or benzyl group can be substituted respectively by 1 to 2 chlorine, bromine, 53 103,996/3 nitro, C-C7 alkoxy, C7-C10 aralkoxy and/or C02R4 radicals with R4 meaning a hydrogen atom, a ^-C6 alkyl, phenyl or benzyl group, R2 and R3, independent of one another, each stand for R1 or a C02R4 group, R5 4 / A stands for a CN, C02R or CON radical, in which R5 and R6, independent of one another, each stand for a hydrogen atom, a saturated or unsaturated, straight-chain, branched-chain or cyclic hydrocarbon radical with up to 16 C atoms optionally interrupted by 1 to 8 oxygen atoms or 1 to 3 phenylene or phenylenoxy groups, and optionally substituted by 1 to 5 hydroxy groups or 1 to 2 C02R radicals; for phenyl or benzyl radicals optionally substituted by 1 to 3 hydroxy or C^-C^ alkoxy groups; or R5 and R6 together with the nitrogen atom stand for a saturated, or unsaturated 5- or 6-ring, optionally containing another nitrogen, oxygen, sulfur atom or a carbonyl group, which optionally is substituted by 1 to 3 C,-C6 alkyl radicals optionally substituted by 1 to 3 hydroxy radicals, and optionally present hydroxy and/or carboxyl groups optionally are protected, wherein tetraazatricyclotridecane or tetraazatricyclopentadecane of formula II 54 103,996/2 is reacted with a feedstock of general formula III in which R, R2, R3 and A have the above-indicated meanings, and optionally present hydroxy and/or carboxyl groups are optionally protected, with or without solvent, preferably aprotic solvents, such as, e.g., benzene, toluene, dichloromethane, tetrahydrofuran, dioxane, acetonitrile, dimethylformamide, hexane or ether, are used as solvent, at 0°C to 210°C, preferably 50°C to 180°C (and in the case of the higher reaction temperature, the solvent used optionally to dissolve the added feedstock of general formula III was distilled off previously in a vacuum), within 12 to 48, preferably 5 to 12 hours; then the thus obtained reaction mixture is cooled to -20 °C to 80 °C, preferably 0° to 30°C, mixed with a mixture of water/organic solvent, such as, e.g., methanol, ethanol, isopropanol, tetrahydrofuran or dioxane, and stirred for 0.5 to 12 hours, preferably 0.5 to 3 hours, at -20°C to room temperature, preferably 0°C to room temperature; then the thus formed — optionally to be isolated — intermediate product carrying a formyl group on a nitrogen atom is reacted by adding an inorganic base such as, e.g., lithium hydroxide, sodium hydroxide, potassium hydroxide, barium hydroxide or calcium hydroxide, preferably sodium hydroxide and potassium hydroxide, or a mineral acid, such as, e.g., hydrochloric, sulfuric or hydrobromic acid, preferably hydrochloric acid, at 0°C to 150°C, preferably room temperature to 120°C, within 1 to 72 hours, preferably 6 to 24 hours, with stirring — optionally followed by subsequent removal of protecting groups in a way usual in the art — to obtain the end product of formula I, which can then be isolated in a way known in the art, preferably as hydrochloride. 55 103,996/2
3. Process according to claim 1 for the production of compounds of general formula I with R meaning a OH I 8 — CH—CH—R group, in which R7 and R3, independent of one another, respectively stand for a hydrogen atom, a Ο,-Ο^ alkyl radical, optionally interrupted by 1 to 10 oxygen atoms, a phenylene, phenylenoxy or phenylenedioxy group, which optionally is substituted by 1 to 3 alkyl, 1 to 3 trifluoromethyl, 1 to 7 hydroxy, 1 to 3 C^-Cj alkoxy, 1 to 3 C7-C10 aralkoxy, 1 to 2 CO-Jl and/or 1 to 2 phenoxy or phenyl groups optionally substituted by 1 to 2 chlorine, bromine, nitro or ,-C6 alkoxy radicals, and the optionally present hydroxy radicals optionally are present in protected form, wherein tetraazatricyclotridecane or tetraazatricyclopentadecane is reacted with a feedstock of general formula IV 7 8 in which R and R have the above-indicated meaning and wherein optionally present hydroxy and/or carboxyl groups optionally are protected, with or without solvent, preferably aprotic solvents, such as, e.g., benzene, toluene, dichloromethane, tetrahydrofuran, dioxane, acetonitrile, dimethylformamide, dimethylacetamide, dimethylsulfoxide, hexane or ether are used as solvent, at 0°C to 220°C, preferably 50°C to 180°C (and in the case of the higher reaction temperature, the solvent optionally used to dissolve the 56 103 ,996/2 added feedstock of general formula IV was previously distilled off in a vacuum) or in an autoclave at an excess pressure of 1 to 100 atm. within 1 to 48 hours, preferably 5 to 12 hours; then the thus obtained reaction mixture is cooled to -20°C to 80 °C, preferably 0°C to 30°C, mixed with a mixture of water/organic solvent, such as, e.g., methanol, ethanol, isopropanol, tetrahydrofuran or dioxane and stirred for 0.5 to 12 hours, preferably 0.5 to 3 hours, at -20°C to room temperature, preferably 0°C to room temperature; then the thus formed — optionally to be isolated — intermediate product carrying a formyl group on a nitrogen atom is reacted by adding an inorganic base, such as, e.g., lithium hydroxide, sodium hydroxide, potassium hydroxide, barium hydroxide or calcium hydroxide, preferably sodium hydroxide and potassium hydroxide, or a mineral acid, such as, e.g., hydrochloric, sulfuric or hydrobromic acid, preferably hydrochloric acid, at 0°C to 150°C, preferably room temperature to 120°C, within 1 to 72 hours, preferably 6 to 24 hours, with stirring — optionally followed by subsequent removal of the protecting groups in a way usual in the art — to obtain the end product of formula I, which can then be isolated in a way known in the art, preferably as hydrochloride. 57 103,996/3
4. Process according to claim 1 for the production of compounds of general formula I with R meaning a -C-NH radical, X in which X means an oxygen or sulfur atom and R9 means a phenyl, 1- or 2-naphthyl or straight-chain or cyclic C,-C6 alkyl group, wherein tetraazatricyclotridecane or tetraazatricyclopenta-decane of formula II is reacted with a feedstock of general formula R9 - N = C = X (V) , 9 . . . in which X and R have the above-indicated meanings, with or without solvent, preferably aprotic solvents, such as, e.g., benzene, toluene, dichloromethane, tetrahydrofuran, dioxane, acetonitrile, dimethylformamide, hexane or ether, are used as solvent, at 0°C to 180°C, preferably room temperature to 150°C (and in the case of the higher reaction temperature, the solvent used optionally to dissolve the added feedstock of general formula V was distilled off previously in a vacuum), within 1 to 48 hours, preferably 5 to 12 hours; then the thus obtained reaction mixture is cooled to -20 °C to 80°C, preferably 0° to 30°C, mixed with a mixture of water/organic solvent, such as, e.g., methanol, ethanol, isopropanol, tetrahydrofuran or dioxane, and stirred for 0.5 to 12 hours, preferably 0.5 to 3 hours, at -20°C to room temperature, preferably 0°C to room temperature; then the thus formed — optionally to be isolated —intermediate product carrying a formyl group on a nitrogen atom 58 103,996/2 is reacted by adding an inorganic base such as, e.g., lithium hydroxide, sodium hydroxide, potassium hydroxide, barium hydroxide or calcium hydroxide, preferably sodium hydroxide and potassium hydroxide, or a mineral acid, such as, e.g., hydrochloric, sulfuric or hydrobromic acid, preferably hydrochloric acid, at 0°c to 150°C, preferably room temperature to 120°C/ within 1 to 72 hours, preferably 6 to 24 hours, with stirring to obtain the end product of formula I, which can then be isolated in a way known in the art, preferably as hydrochloride.
5. Process according to claim 1 for the production of compounds of general formula I with R meaning a - (CH2) 2-NH-S02-R10 radical, in which R10 means a ^-C6 alkyl, -CF3 or a phenyl group optionally substituted by a C,-C6 alkyl, chlorine, bromine or nitro radical, wherein tetraazatricyclotridecane or tetraazatricyclopentadecane is reacted with a feedstock of general formula VI in which R10 has the above-indicated meaning, with solvent, preferably aprotic solvents, such as, e.g., benzene, toluene, dichloromethane, tetrahydrofuran, dioxane, acetonitrile, dimethyIformamide, hexane or ether, are used as solvent, at 0°C to 180°C, preferably room temperature to 150°C (and in the case of the higher reaction temperature, the solvent used was distilled off previously in a vacuum) , within 1 to 48 hours, preferably 5 to 12 hours; 59 103,996/2 then the thus obtained reaction mixture is cooled to -20 °C to 80 °C, preferably 0° to 30°C, mixed with a mixture of water/organic solvent, such as, e.g., methanol, ethanol, isopropanol, tetrahydrofuran or dioxane, and stirred for 0.5 to 12 hours, preferably 0.5 to 3 hours, at -20 °C to room temperature, preferably 0°C to room temperature; then the thus formed — optionally to be isolated — intermediate product carrying a formyl group on a nitrogen atom is reacted by adding an inorganic base such as, e.g., lithium hydroxide, sodium hydroxide, potassium hydroxide, barium hydroxide or calcium hydroxide, preferably sodium hydroxide and potassium hydroxide, or a mineral acid, such as, e.g., hydrochloric, sulfuric or hydrobromic acid, preferably hydrochloric acid, at 0°C to 150°C, preferably room temperature to 120°C, within 1 to 72 hours, preferably 6 to 24 hours, with stirring to obtain the end product of formula I, which can then be isolated in a way known in the art, preferably as hydrochloride.
6. Process according to claim 1 for the production of compounds of general formula I with R meaning a second 1,4,7,10-tetraazacyclododecane or 1 , 4 , 7 , 10-tetraazacyclotetradecanemolecule bound by a bis (B-hydroxy) -alkylene chain -CH,-CH-K-CH-CH,- I I OH OH in which K means a C0-C16 alkylene chain optionally substituted by 1 to 6 hydroxy, 1 to 6 C^-Cj hydroxyalkyl, 1 to 8 ^-C7 alkoxy, 1 to 8 C7-C10 aralkoxy and/or 1 to 2 benzyloxy groups, and optionally interrupted by l to 6 oxygen atoms, 1 to 2 phenylene, phenylenoxy 60 103,996/1 or phenylenedioxy groups, and the optionally present hydroxy groups are optionally in protected form, wherein tetraazatricyclotridecane or tetraazatricyclopentadecane is reacted with a feedstock of general formula VII CH,-CH-K-CH-CH, (VII) , \ / \ / 2 0 0 in which K has the above-indicated meaning, and optionally present hydroxy groups are optionally protected, with or without solvent, preferably aprbtic solvents, such as, e.g., benzene, toluene, dichloromethane, tetrahydrofuran, dioxane, acetonitrile, dimethylformamide, hexane or ether, are used as solvent, at 0°C to 220°C, preferably 50°C to 180°C (and in the case of the higher reaction temperature, the solvent used optionally to dissolve the added feedstock of general formula VII was distilled off previously in a vacuum) or in an autoclave at an excess pressure of 1 to 100 atm. within 1 to 48 hours, preferably 5 to 12 hours; then the thus obtained reaction mixture is cooled to -20°C to 80°C, preferably 0° to 30°C, mixed with a mixture of water/organic solvent, such as, e.g., methanol, ethanol, isppropanol, tetrahydrofuran or dioxane, and stirred for 0.5 to 12 hours, preferably 0.5 to 3 hours, at -20°C to room temperature, preferably 0°C to room temperature; then the thus formed — optionally to be isolated — intermediate product carrying a formyl group on a nitrogen atom is reacted by adding an inorganic base such as, e.g., lithium hydroxide, sodium hydroxide, potassium hydroxide, barium hydroxide or calcium hydroxide, preferably sodium hydroxide and potassium hydroxide, or a mineral acid, such as, e.g., hydrochloric, sulfuric or hydrobromic acid, preferably hydrochloric acid, at 0°C to 150 °C, preferably room temperature to 120°C, within 1 to 72 hours, preferably 6 to 24 hours, with stirring — optionally followed by subsequent removal of protecting groups in a way usual in the art 61 103,996/ 2 — to obtain the end product of formula I, which can then be isolated in a way known in the art, preferably as hydrochloride.
7. A process according to claim 1, wherein the reaction is performed starting from 1,4,7,10-tetraazacyclododecane or 1,4,8,11 -tetraazacyclotetradecane without isolating the intermediate products of formula II to the compounds of general formula I.
8. Use of the mono-N-substituted tetraazacyclododecane and tetraazacyclotetradecane derivatives of general formula I produced according to claims 1 to 7, for the production of metal complexes for diagnosis and treatment, substantially as described in the specification. for the Applicant: WOLFF, BREGMAN AND GOLLER bv: It .
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE4140779A DE4140779A1 (en) | 1991-12-06 | 1991-12-06 | METHOD FOR PRODUCING MONO-N SUBSTITUTED TETRAAZAMACROCYCLES |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL103996A0 IL103996A0 (en) | 1993-05-13 |
| IL103996A true IL103996A (en) | 1998-02-08 |
Family
ID=6446767
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL103996A IL103996A (en) | 1991-12-06 | 1992-12-06 | Process for the production of mono-n-substituted tetraazacyclododecane and tetraazacyclo- tetradecane derivatives |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP0545511B1 (en) |
| JP (1) | JP3471836B2 (en) |
| AT (1) | ATE218131T1 (en) |
| CA (1) | CA2084582C (en) |
| CZ (1) | CZ290232B6 (en) |
| DE (2) | DE4140779A1 (en) |
| DK (1) | DK0545511T3 (en) |
| ES (1) | ES2176183T3 (en) |
| HU (2) | HU9203860D0 (en) |
| IL (1) | IL103996A (en) |
| NO (5) | NO303496B1 (en) |
| PT (1) | PT545511E (en) |
| SK (1) | SK282386B6 (en) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4237943C2 (en) * | 1992-11-06 | 1997-10-23 | Schering Ag | Process for the preparation of metal complexes of N-beta-hydroxyalkyl-tri-N-carboxyalkyl-1,4,7,10-tetraazacyclododecane and N-beta-hydroxyalkyl-tri-N-carboxyalkyl-1,4,8,11-tetraazacyclotetradecane Derivatives |
| DE4317588C2 (en) * | 1993-05-24 | 1998-04-16 | Schering Ag | Macrocyclic metal complexes containing fluorine, process for their preparation and their use |
| DE4318369C1 (en) * | 1993-05-28 | 1995-02-09 | Schering Ag | Use of macrocyclic metal complexes as temperature probes |
| DE4340809C2 (en) * | 1993-11-24 | 2000-08-03 | Schering Ag | 1.4,7,10-tetraazacyclododecane derivatives, pharmaceutical compositions containing them and process for their preparation |
| FR2725449B1 (en) * | 1994-10-05 | 1996-12-27 | Air Liquide | POLYAZACYCLOALCANE DERIVATIVES, THEIR METAL COMPLEXES AND PHARMACEUTICAL PRODUCTS INCORPORATING THESE COMPLEXES |
| DE19724186C2 (en) * | 1997-06-02 | 2002-07-18 | Schering Ag | Process for the mono- and 1,7-bis-N-ß-hydroxyalkylation of cycles and the corresponding N-ß-hydroxyalkyl-1,4,7,10-tetraazacyclododecane-Li salt complexes |
| IT1297035B1 (en) | 1997-12-30 | 1999-08-03 | Bracco Spa | 1,4,7,10-TETRAAZACICLODODECAN-1,4-DIACETIC ACID DERIVATIVES |
| DE19914101C1 (en) * | 1999-03-22 | 2000-10-12 | Schering Ag | Perfluoroalkylamides, their preparation and their use in diagnostics |
| DE10002939C1 (en) * | 2000-01-13 | 2001-09-20 | Schering Ag | New aromatic-substituted tetraazacyclododecane-triacetic acid paramagnetic metal complex compounds, are useful as contrast agents for magnetic resonance imaging of necrotic or infarction tissue |
| JP6124078B2 (en) * | 2010-08-26 | 2017-05-10 | ツイ,クンユァン | Macrocyclic aliphatic compounds and their applications |
| KR20200059319A (en) | 2011-04-21 | 2020-05-28 | 바이엘 인텔렉쳐 프로퍼티 게엠베하 | Preparation of high-purity gadobutrol |
| KR101653064B1 (en) * | 2014-12-26 | 2016-09-09 | 에스티팜 주식회사 | A Method for Gadobutrol |
| KR102033964B1 (en) * | 2018-01-19 | 2019-10-18 | 주식회사 엔지켐생명과학 | Gadoteridol intermediate and method for preparing gadoteridol using the same |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3772785D1 (en) * | 1986-01-23 | 1991-10-17 | Squibb & Sons Inc | 1-SUBSTITUTED-4,7,10-TRISCARBOXYMETHYL-1,4,7,10-TETRAAZACYCLODODECAN AND ANALOG. |
| DE3625417C2 (en) * | 1986-07-28 | 1998-10-08 | Schering Ag | Tetraazacyclododecane derivatives |
| US4994560A (en) * | 1987-06-24 | 1991-02-19 | The Dow Chemical Company | Functionalized polyamine chelants and radioactive rhodium complexes thereof for conjugation to antibodies |
| FR2644453A1 (en) * | 1989-03-20 | 1990-09-21 | Centre Nat Rech Scient | PROCESS FOR THE PREPARATION OF MONOFUNCTIONALIZED CYCLIC TETRAMINES |
| AU625529B2 (en) * | 1989-12-22 | 1992-07-16 | E.R. Squibb & Sons, Inc. | 10-(2'-hydroxy-3'-alkoxy-1,4,7-triscarboxymethyl-1,4,7,10- tetraazacyclododecanes |
| NZ236267A (en) * | 1989-12-22 | 1992-12-23 | Squibb & Sons Inc | 10-(2'-hydroxy-3'-polyoxaalkyl)-1,4,7-triscarboxymethyl-1,4,7,10-tetraazacyclododecane |
| DE4009119A1 (en) * | 1990-03-19 | 1991-09-26 | Schering Ag | 1,4,7,10-TETRAAZACYCLODODECANE-BUTYLTRIOLS, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL AGENTS CONTAINING THEM |
| DE4035760A1 (en) * | 1990-11-08 | 1992-05-14 | Schering Ag | MONO-N-SUBSTITUTED 1,4,7,10-TETRAAZACYCLODODECAN DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL AGENTS CONTAINING THEM |
-
1991
- 1991-12-06 DE DE4140779A patent/DE4140779A1/en not_active Withdrawn
-
1992
- 1992-12-03 DE DE59209957T patent/DE59209957D1/en not_active Expired - Lifetime
- 1992-12-03 EP EP92250351A patent/EP0545511B1/en not_active Expired - Lifetime
- 1992-12-03 PT PT92250351T patent/PT545511E/en unknown
- 1992-12-03 ES ES92250351T patent/ES2176183T3/en not_active Expired - Lifetime
- 1992-12-03 AT AT92250351T patent/ATE218131T1/en active
- 1992-12-03 DK DK92250351T patent/DK0545511T3/en active
- 1992-12-04 NO NO924690A patent/NO303496B1/en not_active IP Right Cessation
- 1992-12-04 CZ CS19923573A patent/CZ290232B6/en not_active IP Right Cessation
- 1992-12-04 CA CA002084582A patent/CA2084582C/en not_active Expired - Lifetime
- 1992-12-04 SK SK3573-92A patent/SK282386B6/en not_active IP Right Cessation
- 1992-12-04 HU HU9203860A patent/HU9203860D0/en unknown
- 1992-12-04 HU HU9203860A patent/HU224923B1/en unknown
- 1992-12-06 IL IL103996A patent/IL103996A/en not_active IP Right Cessation
- 1992-12-07 JP JP32657092A patent/JP3471836B2/en not_active Expired - Lifetime
-
1997
- 1997-08-04 NO NO973578A patent/NO303384B1/en not_active IP Right Cessation
- 1997-08-04 NO NO973579A patent/NO303387B1/en not_active IP Right Cessation
- 1997-08-04 NO NO973581A patent/NO303385B1/en not_active IP Right Cessation
- 1997-08-04 NO NO973580A patent/NO303386B1/en not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5410043A (en) | Process for the production of mono-N-substituted tetraaza macrocycles | |
| IL103996A (en) | Process for the production of mono-n-substituted tetraazacyclododecane and tetraazacyclo- tetradecane derivatives | |
| JP2012056967A (en) | Process for preparation of n-1 protected n ring nitrogen-containing cyclic polyamine and product thereof | |
| CA2107196A1 (en) | Carboxamide derivatives | |
| CZ301594A3 (en) | Process for preparing derivatives of n-beta-hydroxyalkyl-tri-n-carboxyalkyl-1,4,7,10-tetraazocyclododecane and n-beta-hydroxyalkyl-tri-n-carboxyalkyl-1,4,8,11-tetraazocyclotetradecane and their metal complexes | |
| US5587451A (en) | Process for preparing polyazamacrocycles | |
| Kovacs et al. | pH-controlled selective protection of polyaza macrocycles | |
| EP0545983B1 (en) | Intermediates for chelating agents with prefixed symmetry and process for their preparation | |
| IL107394A (en) | Process for the preparation of metal complexes of tetraazacycloalkane derivatives | |
| CA2247265C (en) | Process for preparing 1,4,7,10-tetraazacyclododecane and its derivatives | |
| EP0730616B1 (en) | Process for preparing polyazamacrocycles | |
| Zhou et al. | Convenient and efficient synthesis of imidazolium cyclophanes | |
| AU2017223532A1 (en) | New toxin and method for preparing intermediate thereof | |
| AU610629B2 (en) | Improvements in or relating to leukotriene antagonists | |
| CA1301753C (en) | Process for preparing histamine h_-antagonist and intermediates used in such process | |
| WO2009072062A2 (en) | Novel derivatives of dihydroxypyrrolidine as anti-cancer compounds | |
| Abd El Latif et al. | Novel synthesis of 3‐phenylazo‐1, 5‐benzothiazepines,‐1, 5‐benzoxazepines and‐1, 5‐benzodiazepines via a one‐pot reaction | |
| KR100417624B1 (en) | Novel Decursin Derivatives | |
| JP2001247573A (en) | FR900482 analogs and methods for their synthesis | |
| Jakubkene et al. | Synthesis and Reactions of (6-Methyl-2-methylsulfanyl-4-oxo-3, 4-dihydro-3-pyrimidinyl) acetyl Azide | |
| HK1058035B (en) | Process for preparation of n-1 protected n ring nitrogen containing cyclic polyamines and products thereof | |
| JPH11158182A (en) | Bisepoxy-1,5,7,11-tetraoxaspiro [5.5] undecane derivative and method for producing the same |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FF | Patent granted | ||
| KB | Patent renewed | ||
| KB | Patent renewed | ||
| KB | Patent renewed | ||
| KB | Patent renewed | ||
| EXP | Patent expired |